1
|
Ubeda C, Vano E, Perez MD, Jímenez P, Ramirez R, Nader A, Miranda P, Azcurra P, Damsky J, Capdevila S, Oliveira M, Albuquerque J, Bocamino R, Schelin H, Yagui A, Aguirre D, Riquelme N, Cardenas L, Álvarez A, Mosquera W, Arias F, Gutierrez R, De la Mora R, Rivera T, Zapata J, Araujo P, Chiesa P. Setting up regional diagnostic reference levels for pediatric interventional cardiology in Latin America and the Caribbean countries: preliminary results and identified challenges. J Radiol Prot 2022; 42:031513. [PMID: 35940166 DOI: 10.1088/1361-6498/ac87b7] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/30/2022] [Accepted: 08/08/2022] [Indexed: 06/15/2023]
Abstract
The goal of the present study was to propose a set of preliminary regional diagnostic reference levels (DRLs) for pediatric interventional cardiology (IC) procedures in Latin America and the Caribbean countries, classified by age and weight groups. The study was conducted in the framework of the Optimization of Protection in Pediatric Interventional Radiology in Latin America and the Caribbean program coordinated by the World Health Organization and the Pan American Health Organization in cooperation with the International Atomic Energy Agency. The first step of the program was focused on pediatric IC. Dose data from diagnostic and therapeutic procedures were collected between December 2020 and December 2021. Regional DRLs were set as the third quartile of patient dose data (kerma area product) collected in 18 hospitals from 10 countries in an initial sample of 968 procedures. DRLs were set for four age bands and five weight ranges. The values obtained for the four age bands (<1 yr, 1 to <5 yr, 5 to <10 yr and 10 to <16 yr) were 2.9, 6.1, 8.8 and 14.4 Gy cm2for diagnostic procedures, and 4.0, 5.0, 10.0 and 38.1 Gy cm2for therapeutic procedures, respectively. The values obtained for the five weight bands (<5 kg, 5 to <15 kg, 15 to <30 kg, 30 to <50 kg and 50 to <80 kg) were 3.0, 4.5, 8.1, 9.2 and 26.8 Gy cm2for diagnostic procedures and 3.7, 4,3, 7.3, 16.1 and 53.4 Gy cm2for therapeutic procedures, respectively. While initial data were collected manually as patient dose management systems (DMSs) were not available in most of the hospitals involved in the program, a centralized automatic DMS for the collection and management of patient dose indicators has now been introduced and is envisaged to increase the sample size. The possibility of alerting on high dose values and introducing corrective actions will help in optimization.
Collapse
Affiliation(s)
- C Ubeda
- Departamento de Tecnología Médica, Facultad de Ciencias de la Salud, Universidad de Tarapacá, Arica, Chile
| | - E Vano
- Radiology Department, Faculty of Medicine, Complutense University and IdIS, San Carlos Hospital, 28040 Madrid, Spain
| | - M D Perez
- World Health Organization (WHO), Geneva, Switzerland
| | - P Jímenez
- Pan American Health Organization (PAHO), Washington, DC, United States of America
| | - R Ramirez
- International Atomic Energy Agency (IAEA), Vienna, Austria
| | - A Nader
- International Atomic Energy Agency (IAEA), Vienna, Austria
| | - P Miranda
- Luis Calvo Mackenna's Hospital, AntonioVaras 360, Santiago, Chile
| | - P Azcurra
- Hemodynamic Service, Italian Hospital, Buenos Aires, Argentina
| | - J Damsky
- Hemodynamic Service, Pedro de Elizalde Children's Hospital, Buenos Aires, Argentina
| | - S Capdevila
- Hemodynamic Service, Santísima Trinidad Children's Hospital, Córdova, Argentina
| | - M Oliveira
- Department of Health Technology and Biology, Federal Institute of Bahia, Salvador, Brazil
| | - J Albuquerque
- University Hospital of the Federal University of Maranhão, San Luis, Brasil
| | - R Bocamino
- Clinical Hospital of the Federal University of Paraná, Curitiba, Brasil
| | - H Schelin
- Pequeno Príncipe Hospital, Curitiba, Brasil
| | - A Yagui
- Pequeno Príncipe Hospital, Curitiba, Brasil
| | - D Aguirre
- Hemodynamic Service, Roberto del Rio Children's, Santiago, Chile
| | - N Riquelme
- Hemodynamic Service, Roberto del Rio Children's, Santiago, Chile
| | - L Cardenas
- Hemodynamic Service, Santa Maria Clinic, Santiago, Chile
| | - A Álvarez
- Hemodynamic Service, Santa Maria Clinic, Santiago, Chile
| | - W Mosquera
- Valle del Lili Foundation University Hospital ICESI, Cali, Colombia
| | - F Arias
- National Children's Hospital, San José, Costa Rica
| | - R Gutierrez
- National Children's Hospital, San José, Costa Rica
| | - R De la Mora
- National Directorate of Environmental Health, Ministry of Public Health, Havana, Cuba
| | - T Rivera
- Center for Research in Applied Sciences and Advanced Technology Legaria, IPN, Ciudad de México, Mexico
| | - J Zapata
- National Institute of Child Health St. Borja, Lima, Peru
| | - P Araujo
- National Cardiovascular Institute, Lima, Peru
| | - P Chiesa
- Children's Cardiology Institute, Montevideo, Uruguay
| |
Collapse
|
2
|
Felín MS, Wang K, Raggi C, Moreira A, Pandey A, Grose A, Caballero Z, Rengifo-Herrera C, Ramirez M, Moossazadeh D, Castro C, Montalvo JLS, Leahy K, Zhou Y, Clouser FA, Siddiqui M, Leong N, Goodall P, Michalowski M, Ismail M, Christmas M, Schrantz S, Norero X, Estripeaut D, Ellis D, Ashi K, Dovgin S, Dixon A, Li X, Begeman I, Heichman S, Lykins J, Villalobos-Cerrud D, Fabrega L, Mendivil C, Quijada MR, Fernández-Pirla S, de La Guardia V, Wong D, de LadrónGuevara M, Flores C, Borace J, García A, Caballero N, de Saez MTM, Politis M, Ross S, Dogra M, Dhamsania V, Graves N, Kirchberg M, Mathur K, Aue A, Restrepo CM, Llanes A, Guzman G, Rebollon A, Boyer K, Heydemann P, Noble AG, Swisher C, Rabiah P, Withers S, Hull T, Su C, Blair M, Latkany P, Mui E, Vasconcelos-Santos DV, Villareal A, Perez A, Galvis CAN, Montes MV, Perez NIC, Ramirez M, Chittenden C, Wang E, Garcia-López LL, Muñoz-Ortiz J, Rivera-Valdivia N, Bohorquez-Granados MC, de-la-Torre GC, Padrieu G, Hernandez JDV, Celis-Giraldo D, Acosta Dávila JA, Torres E, Oquendo MM, Arteaga-Rivera JY, Nicolae D, Rzhetsky A, Roizen N, Stillwaggon E, Sawers L, Peyron F, Wallon M, Chapey E, Levigne P, Charter C, De Frias M, Montoya J, Press C, Ramirez R, Contopoulos-Ioannidis D, Maldonado Y, Liesenfeld O, Gomez C, Wheeler K, Holfels E, Frim D, McLone D, Penn R, Cohen W, Zehar S, McAuley J, Limonne D, Houze S, Abraham S, Piarroux R, Tesic V, Beavis K, Abeleda A, Sautter M, El Mansouri B, El Bachir A, Amarir F, El Bissati K, de-la-Torre A, Britton G, Motta J, Ortega-Barria E, Romero IL, Meier P, Grigg M, Gómez-Marín J, Kosagisharaf JR, Llorens XS, Reyes O, McLeod R. Building Programs to Eradicate Toxoplasmosis Part III: Epidemiology and Risk Factors. Curr Pediatr Rep 2022; 10:109-124. [PMID: 37744780 PMCID: PMC10516319 DOI: 10.1007/s40124-022-00265-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 04/29/2022] [Indexed: 11/25/2022]
Abstract
Purpose of Review Review comprehensive data on rates of toxoplasmosis in Panama and Colombia. Recent Findings Samples and data sets from Panama and Colombia, that facilitated estimates regarding seroprevalence of antibodies to Toxoplasma and risk factors, were reviewed. Summary Screening maps, seroprevalence maps, and risk factor mathematical models were devised based on these data. Studies in Ciudad de Panamá estimated seroprevalence at between 22 and 44%. Consistent relationships were found between higher prevalence rates and factors such as poverty and proximity to water sources. Prenatal screening rates for anti-Toxoplasma antibodies were variable, despite existence of a screening law. Heat maps showed a correlation between proximity to bodies of water and overall Toxoplasma seroprevalence. Spatial epidemiological maps and mathematical models identify specific regions that could most benefit from comprehensive, preventive healthcare campaigns related to congenital toxoplasmosis and Toxoplasma infection.
Collapse
Affiliation(s)
| | - Kanix Wang
- Institute for Genomics and Systems Biology, The University
of Chicago, Chicago, IL, USA
| | - Catalina Raggi
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
- Instituto de Investigaciones Científicas Y Servicios
de Alta Tecnología AIP (INDICASAT-AIP), Ciudad de Panamá, Panama
- Department of Pediatrics Infectious Diseases/Department of
Neonatology, Hospital del Niño Doctor José Renán Esquivel,
Ciudad de Panamá, Panama
- Department of Ophthalmology and Visual Sciences, The
University of Chicago, Chicago, IL, USA
- The College, The University of Chicago, Chicago, IL,
USA
- The Global Health Center, The University of Chicago,
Chicago, IL, USA
| | - Aliya Moreira
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
- The College, The University of Chicago, Chicago, IL,
USA
- The Global Health Center, The University of Chicago,
Chicago, IL, USA
| | - Abhinav Pandey
- Department of Ophthalmology and Visual Sciences, The
University of Chicago, Chicago, IL, USA
- The College, The University of Chicago, Chicago, IL,
USA
- The Global Health Center, The University of Chicago,
Chicago, IL, USA
| | - Andrew Grose
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
| | - Zuleima Caballero
- Instituto de Investigaciones Científicas Y Servicios
de Alta Tecnología AIP (INDICASAT-AIP), Ciudad de Panamá, Panama
| | | | - Margarita Ramirez
- Department of Ophthalmology and Visual Sciences, The
University of Chicago, Chicago, IL, USA
- The College, The University of Chicago, Chicago, IL,
USA
- The Global Health Center, The University of Chicago,
Chicago, IL, USA
| | - Davina Moossazadeh
- The College, The University of Chicago, Chicago, IL,
USA
- The Global Health Center, The University of Chicago,
Chicago, IL, USA
- Department of Statistics, The University of Chicago,
Chicago, IL, USA
| | - Catherine Castro
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
- Department of Ophthalmology and Visual Sciences, The
University of Chicago, Chicago, IL, USA
| | - José Luis Sanchez Montalvo
- Department of Ophthalmology and Visual Sciences, The
University of Chicago, Chicago, IL, USA
- The College, The University of Chicago, Chicago, IL,
USA
| | - Karen Leahy
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
| | - Ying Zhou
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
| | | | - Maryam Siddiqui
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
| | - Nicole Leong
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
| | - Perpetua Goodall
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
| | - Morgan Michalowski
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
| | - Mahmoud Ismail
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
| | - Monica Christmas
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
| | - Stephen Schrantz
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
| | - Ximena Norero
- Department of Pediatrics Infectious Diseases/Department of
Neonatology, Hospital del Niño Doctor José Renán Esquivel,
Ciudad de Panamá, Panama
| | - Dora Estripeaut
- Department of Pediatrics Infectious Diseases/Department of
Neonatology, Hospital del Niño Doctor José Renán Esquivel,
Ciudad de Panamá, Panama
| | - David Ellis
- Department of Pediatrics Infectious Diseases/Department of
Neonatology, Hospital del Niño Doctor José Renán Esquivel,
Ciudad de Panamá, Panama
| | - Kevin Ashi
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
| | - Samantha Dovgin
- Department of Ophthalmology and Visual Sciences, The
University of Chicago, Chicago, IL, USA
- The College, The University of Chicago, Chicago, IL,
USA
| | - Ashtyn Dixon
- Department of Ophthalmology and Visual Sciences, The
University of Chicago, Chicago, IL, USA
| | - Xuan Li
- Rush University Medical School/Rush University Medical
Center, Chicago, IL, USA
| | - Ian Begeman
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
- Department of Ophthalmology and Visual Sciences, The
University of Chicago, Chicago, IL, USA
| | - Sharon Heichman
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
- Department of Ophthalmology and Visual Sciences, The
University of Chicago, Chicago, IL, USA
| | - Joseph Lykins
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
- Department of Ophthalmology and Visual Sciences, The
University of Chicago, Chicago, IL, USA
| | - Delba Villalobos-Cerrud
- Instituto de Investigaciones Científicas Y Servicios
de Alta Tecnología AIP (INDICASAT-AIP), Ciudad de Panamá, Panama
| | - Lorena Fabrega
- Instituto de Investigaciones Científicas Y Servicios
de Alta Tecnología AIP (INDICASAT-AIP), Ciudad de Panamá, Panama
| | - Connie Mendivil
- Instituto de Investigaciones Científicas Y Servicios
de Alta Tecnología AIP (INDICASAT-AIP), Ciudad de Panamá, Panama
| | - Mario R. Quijada
- Instituto de Investigaciones Científicas Y Servicios
de Alta Tecnología AIP (INDICASAT-AIP), Ciudad de Panamá, Panama
| | - Silvia Fernández-Pirla
- Toxoplasmosis Programs and Initiatives in Panamá,
Ciudad de Panamá, Panama
- Academia Interamericana de Panamá, Ciudad de
Panamá, Panama
| | - Valli de La Guardia
- Instituto de Investigaciones Científicas Y Servicios
de Alta Tecnología AIP (INDICASAT-AIP), Ciudad de Panamá, Panama
| | - Digna Wong
- Instituto de Investigaciones Científicas Y Servicios
de Alta Tecnología AIP (INDICASAT-AIP), Ciudad de Panamá, Panama
| | - Mayrene de LadrónGuevara
- Instituto de Investigaciones Científicas Y Servicios
de Alta Tecnología AIP (INDICASAT-AIP), Ciudad de Panamá, Panama
| | | | | | - Anabel García
- Instituto de Investigaciones Científicas Y Servicios
de Alta Tecnología AIP (INDICASAT-AIP), Ciudad de Panamá, Panama
| | | | - Maria Theresa Moreno de Saez
- Department of Pediatrics Infectious Diseases/Department of
Neonatology, Hospital del Niño Doctor José Renán Esquivel,
Ciudad de Panamá, Panama
| | - Michael Politis
- Toxoplasmosis Programs and Initiatives in Panamá,
Ciudad de Panamá, Panama
| | - Stephanie Ross
- Rush University Medical School/Rush University Medical
Center, Chicago, IL, USA
| | - Mimansa Dogra
- Department of Ophthalmology and Visual Sciences, The
University of Chicago, Chicago, IL, USA
| | - Vishan Dhamsania
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
- Capstone Program, Global Health Center, The University of
Chicago, Chicago, IL, USA
| | - Nicholas Graves
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
- Capstone Program, Global Health Center, The University of
Chicago, Chicago, IL, USA
| | - Marci Kirchberg
- Capstone Program, Global Health Center, The University of
Chicago, Chicago, IL, USA
- Harris School of Public Policy, The University of
Chicago, Chicago, IL, USA
| | - Kopal Mathur
- Capstone Program, Global Health Center, The University of
Chicago, Chicago, IL, USA
- Harris School of Public Policy, The University of
Chicago, Chicago, IL, USA
| | - Ashley Aue
- Harris School of Public Policy, The University of
Chicago, Chicago, IL, USA
| | - Carlos M. Restrepo
- Instituto de Investigaciones Científicas Y Servicios
de Alta Tecnología AIP (INDICASAT-AIP), Ciudad de Panamá, Panama
| | - Alejandro Llanes
- Instituto de Investigaciones Científicas Y Servicios
de Alta Tecnología AIP (INDICASAT-AIP), Ciudad de Panamá, Panama
| | - German Guzman
- Instituto de Investigaciones Científicas Y Servicios
de Alta Tecnología AIP (INDICASAT-AIP), Ciudad de Panamá, Panama
| | - Arturo Rebollon
- Sanofi Aventis de Panamá S.A, University of South
Florida, Ciudad de Panamá, Panama
| | - Kenneth Boyer
- Rush University Medical School/Rush University Medical
Center, Chicago, IL, USA
| | - Peter Heydemann
- Rush University Medical School/Rush University Medical
Center, Chicago, IL, USA
| | - A. Gwendolyn Noble
- Department of Ophthalmology and Visual Sciences, The
University of Chicago, Chicago, IL, USA
- Northwestern University Feinberg School of Medicine,
Chicago, IL, USA
| | - Charles Swisher
- Northwestern University Feinberg School of Medicine,
Chicago, IL, USA
| | | | - Shawn Withers
- Department of Ophthalmology and Visual Sciences, The
University of Chicago, Chicago, IL, USA
| | - Teri Hull
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
| | - Chunlei Su
- Department of Microbiology, The University of Tennessee,
Knoxville, TN, USA
| | - Michael Blair
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
- Department of Ophthalmology and Visual Sciences, The
University of Chicago, Chicago, IL, USA
| | - Paul Latkany
- Department of Ophthalmology and Visual Sciences, The
University of Chicago, Chicago, IL, USA
| | - Ernest Mui
- Department of Ophthalmology and Visual Sciences, The
University of Chicago, Chicago, IL, USA
| | | | - Alcibiades Villareal
- Instituto de Investigaciones Científicas Y Servicios
de Alta Tecnología AIP (INDICASAT-AIP), Ciudad de Panamá, Panama
| | - Ambar Perez
- Instituto de Investigaciones Científicas Y Servicios
de Alta Tecnología AIP (INDICASAT-AIP), Ciudad de Panamá, Panama
| | | | | | | | - Morgan Ramirez
- The College, The University of Chicago, Chicago, IL,
USA
| | - Cy Chittenden
- The College, The University of Chicago, Chicago, IL,
USA
| | - Edward Wang
- The College, The University of Chicago, Chicago, IL,
USA
| | | | - Juliana Muñoz-Ortiz
- Grupo de Investigación en Neurociencias,
Universidad del Rosario, Bogotá, Colombia
| | | | | | | | - Guillermo Padrieu
- The University of South Florida College of Public Health,
Tampa, FL, USA
| | | | - Daniel Celis-Giraldo
- Grupo de Investigación en Neurociencias,
Universidad del Rosario, Bogotá, Colombia
| | | | - Elizabeth Torres
- Grupo de Investigación en Neurociencias,
Universidad del Rosario, Bogotá, Colombia
| | | | | | - Dan Nicolae
- Department of Statistics, The University of Chicago,
Chicago, IL, USA
| | - Andrey Rzhetsky
- Institute for Genomics and Systems Biology, The University
of Chicago, Chicago, IL, USA
| | - Nancy Roizen
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
| | | | - Larry Sawers
- Department of Economics, American University, Washington,
D.C, USA
| | - Francois Peyron
- Institut Des Agents Infectieux, Hôpital de La
Croix-Rousse, Lyon, France
| | - Martine Wallon
- Institut Des Agents Infectieux, Hôpital de La
Croix-Rousse, Lyon, France
| | - Emanuelle Chapey
- Institut Des Agents Infectieux, Hôpital de La
Croix-Rousse, Lyon, France
| | - Pauline Levigne
- Institut Des Agents Infectieux, Hôpital de La
Croix-Rousse, Lyon, France
| | | | | | - Jose Montoya
- Remington Specialty Laboratory, Palo Alto, CA, USA
| | - Cindy Press
- Remington Specialty Laboratory, Palo Alto, CA, USA
| | | | - Despina Contopoulos-Ioannidis
- Department of Pediatrics, Division of Infectious
Diseases, Stanford University College of Medicine, Stanford, CA, USA
| | - Yvonne Maldonado
- Department of Pediatrics, Division of Infectious
Diseases, Stanford University College of Medicine, Stanford, CA, USA
| | | | - Carlos Gomez
- Department of Economics, Gettysburg College, Gettysburg,
PA, USA
| | - Kelsey Wheeler
- Department of Ophthalmology and Visual Sciences, The
University of Chicago, Chicago, IL, USA
| | - Ellen Holfels
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
| | - David Frim
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
| | - David McLone
- Northwestern University Feinberg School of Medicine,
Chicago, IL, USA
| | - Richard Penn
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
| | - William Cohen
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
| | - Samantha Zehar
- Northwestern University Feinberg School of Medicine,
Chicago, IL, USA
| | - James McAuley
- Department of Ophthalmology and Visual Sciences, The
University of Chicago, Chicago, IL, USA
| | | | - Sandrine Houze
- Laboratory of Parasitologie, Bichat-Claude Bernard
Hopital, Paris, France
| | - Sylvie Abraham
- Laboratory of Parasitologie, Bichat-Claude Bernard
Hopital, Paris, France
| | | | - Vera Tesic
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
| | - Kathleen Beavis
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
| | - Ana Abeleda
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
| | - Mari Sautter
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
| | | | | | - Fatima Amarir
- Faculty of Sciences Aïn Chok, University Hassan
II, Casablanca, Morocco
| | - Kamal El Bissati
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
- INH, Rabat, Morocco
| | | | - Gabrielle Britton
- Instituto de Investigaciones Científicas Y Servicios
de Alta Tecnología AIP (INDICASAT-AIP), Ciudad de Panamá, Panama
- Sistema Nacional de Investigadores de Panamá
(SNI), Clayton, Panama
| | - Jorge Motta
- Tecnología E Innovación (SENACYT),
Secretaría Nacional de Ciencia, Ciudad de Panamá, Panama
| | - Eduardo Ortega-Barria
- Tecnología E Innovación (SENACYT),
Secretaría Nacional de Ciencia, Ciudad de Panamá, Panama
- GSK Vaccines, Panamá, Panama
| | - Isabel Luz Romero
- Tecnología E Innovación (SENACYT),
Secretaría Nacional de Ciencia, Ciudad de Panamá, Panama
| | - Paul Meier
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
| | - Michael Grigg
- Molecular Parasitology Section Laboratory of Parasitic
Diseases, National Institutes of Health, NIAID, Bethesda, MD, USA
| | | | - Jagannatha Rao Kosagisharaf
- Instituto de Investigaciones Científicas Y Servicios
de Alta Tecnología AIP (INDICASAT-AIP), Ciudad de Panamá, Panama
| | - Xavier Sáez Llorens
- Department of Pediatrics Infectious Diseases/Department of
Neonatology, Hospital del Niño Doctor José Renán Esquivel,
Ciudad de Panamá, Panama
- Sistema Nacional de Investigadores de Panamá
(SNI), Clayton, Panama
| | - Osvaldo Reyes
- Academia Interamericana de Panamá, Ciudad de
Panamá, Panama
- Hospital Santo Tomás, Ciudad de Panamá,
Panama
- Sistema Nacional de Investigadores de Panamá
(SNI), Clayton, Panama
| | - Rima McLeod
- Toxoplasmosis Programs and Initiatives in Panamá,
Ciudad de Panamá, Panama
- Institute for Genomics and Systems Biology, The University
of Chicago, Chicago, IL, USA
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
- Department of Ophthalmology and Visual Sciences, The
University of Chicago, Chicago, IL, USA
- The College, The University of Chicago, Chicago, IL,
USA
- The Global Health Center, The University of Chicago,
Chicago, IL, USA
- Toxoplasmosis Center, The University of Chicago, and
Toxoplasmosis Research Institute, Chicago, IL, USA
- Department of Pediatrics (Infectious Diseases), The
University of Chicago, Chicago, IL, USA
| |
Collapse
|
3
|
Cockrum P, MacEwan J, Ramirez R. EP14.05-015 Quantifying Recent Trends in Real-World Treatment Patterns Among Adults Diagnosed with Small Cell Lung Cancer in the U.S. from 2013-2021. J Thorac Oncol 2022. [DOI: 10.1016/j.jtho.2022.07.990] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
|
4
|
Felín MS, Wang K, Moreira A, Grose A, Leahy K, Zhou Y, Clouser FA, Siddiqui M, Leong N, Goodall P, Michalowski M, Ismail M, Christmas M, Schrantz S, Caballero Z, Norero X, Estripeaut D, Ellis D, Raggi C, Castro C, Rengifo-Herrera C, Moossazadeh D, Ramirez M, Pandey A, Ashi K, Dovgin S, Dixon A, Li X, Begeman I, Heichman S, Lykins J, Villalobos-Cerrud D, Fabrega L, Montalvo JLS, Mendivil C, Quijada MR, Fernández-Pirla S, de La Guardia V, Wong D, de Guevara ML, Flores C, Borace J, García A, Caballero N, de Saez MTM, Politis M, Ross S, Dogra M, Dhamsania V, Graves N, Kirchberg M, Mathur K, Aue A, Restrepo CM, Llanes A, Guzman G, Rebellon A, Boyer K, Heydemann P, Noble AG, Swisher C, Rabiah P, Withers S, Hull T, Frim D, McLone D, Su C, Blair M, Latkany P, Mui E, Vasconcelos-Santos DV, Villareal A, Perez A, Galvis CAN, Montes MV, Perez NIC, Ramirez M, Chittenden C, Wang E, Garcia-López LL, Muñoz-Ortiz J, Rivera-Valdivia N, Bohorquez-Granados MC, de-la-Torre GC, Padrieu G, Hernandez JDV, Celis-Giraldo D, Dávila JAA, Torres E, Oquendo MM, Arteaga-Rivera JY, Nicolae DL, Rzhetsky A, Roizen N, Stillwaggon E, Sawers L, Peyron F, Wallon M, Chapey E, Levigne P, Charter C, De Frias M, Montoya J, Press C, Ramirez R, Contopoulos-Ioannidis D, Maldonado Y, Liesenfeld O, Gomez C, Wheeler K, Zehar S, McAuley J, Limonne D, Houze S, Abraham S, Piarroux R, Tesic V, Beavis K, Abeleda A, Sautter M, El Mansouri B, El Bachir A, Amarir F, El Bissati K, Holfels E, Penn R, Cohen W, de-la-Torre A, Britton G, Motta J, Ortega-Barria E, Romero IL, Meier P, Grigg M, Gómez-Marín J, Kosagisharaf JR, Llorens XS, Reyes O, McLeod R. Building Programs to Eradicate Toxoplasmosis Part II: Education. Curr Pediatr Rep 2022; 10:93-108. [PMID: 36969368 PMCID: PMC10035399 DOI: 10.1007/s40124-022-00267-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
Abstract
Abstract
Purpose of Review
Review work to create and evaluate educational materials that could serve as a primary prevention strategy to help both providers and patients in Panama, Colombia, and the USA reduce disease burden of Toxoplasma infections.
Recent Findings
Educational programs had not been evaluated for efficacy in Panama, USA, or Colombia.
Summary
Educational programs for high school students, pregnant women, medical students and professionals, scientists, and lay personnel were created. In most settings, short-term effects were evaluated. In Panama, Colombia, and USA, all materials showed short-term utility in transmitting information to learners. These educational materials can serve as a component of larger public health programs to lower disease burden from congenital toxoplasmosis. Future priorities include conducting robust longitudinal studies of whether education correlates with reduced adverse disease outcomes, modifying educational materials as new information regarding region-specific risk factors is discovered, and ensuring materials are widely accessible.
Collapse
Affiliation(s)
| | - Kanix Wang
- Institute for Genomics and Systems Biology, The University
of Chicago, Chicago, IL, USA
| | - Aliya Moreira
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
- Instituto de Investigaciones Científicas y Servicios
de Alta Tecnología AIP (INDICASAT-AIP), Panama City, Panama
- Department of Pediatrics Infectious Diseases/Department of
Neonatology, Hospital del Niño Doctor José Renán Esquivel,
Panama City, Panama
- Department of Ophthalmology and Visual Sciences, The
University of Chicago, Chicago, IL, USA
- The College, The University of Chicago, Chicago, IL,
USA
- The Global Health Center, The University of Chicago,
Chicago, IL, USA
| | - Andrew Grose
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
- Department of Ophthalmology and Visual Sciences, The
University of Chicago, Chicago, IL, USA
- The Global Health Center, The University of Chicago,
Chicago, IL, USA
| | - Karen Leahy
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
| | - Ying Zhou
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
| | | | - Maryam Siddiqui
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
| | - Nicole Leong
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
| | - Perpetua Goodall
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
| | - Morgan Michalowski
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
| | - Mahmoud Ismail
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
| | - Monica Christmas
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
| | - Stephen Schrantz
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
| | - Zuleima Caballero
- Instituto de Investigaciones Científicas y Servicios
de Alta Tecnología AIP (INDICASAT-AIP), Panama City, Panama
| | - Ximena Norero
- Department of Pediatrics Infectious Diseases/Department of
Neonatology, Hospital del Niño Doctor José Renán Esquivel,
Panama City, Panama
| | - Dora Estripeaut
- Department of Pediatrics Infectious Diseases/Department of
Neonatology, Hospital del Niño Doctor José Renán Esquivel,
Panama City, Panama
| | - David Ellis
- Department of Pediatrics Infectious Diseases/Department of
Neonatology, Hospital del Niño Doctor José Renán Esquivel,
Panama City, Panama
| | - Catalina Raggi
- Department of Ophthalmology and Visual Sciences, The
University of Chicago, Chicago, IL, USA
- The College, The University of Chicago, Chicago, IL,
USA
- The Global Health Center, The University of Chicago,
Chicago, IL, USA
| | - Catherine Castro
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
- Department of Ophthalmology and Visual Sciences, The
University of Chicago, Chicago, IL, USA
- The Global Health Center, The University of Chicago,
Chicago, IL, USA
| | - Claudia Rengifo-Herrera
- Instituto de Investigaciones Científicas y Servicios
de Alta Tecnología AIP (INDICASAT-AIP), Panama City, Panama
- Universidad de Panamá, Panama City, Panama
| | - Davina Moossazadeh
- Department of Ophthalmology and Visual Sciences, The
University of Chicago, Chicago, IL, USA
- The College, The University of Chicago, Chicago, IL,
USA
- The Global Health Center, The University of Chicago,
Chicago, IL, USA
- Department of Statistics, The University of Chicago,
Chicago, IL, USA
| | - Margarita Ramirez
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
- Department of Ophthalmology and Visual Sciences, The
University of Chicago, Chicago, IL, USA
- The College, The University of Chicago, Chicago, IL,
USA
- The Global Health Center, The University of Chicago,
Chicago, IL, USA
| | - Abhinav Pandey
- Department of Ophthalmology and Visual Sciences, The
University of Chicago, Chicago, IL, USA
- The College, The University of Chicago, Chicago, IL,
USA
- The Global Health Center, The University of Chicago,
Chicago, IL, USA
| | - Kevin Ashi
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
- Department of Ophthalmology and Visual Sciences, The
University of Chicago, Chicago, IL, USA
- The Global Health Center, The University of Chicago,
Chicago, IL, USA
| | - Samantha Dovgin
- Department of Ophthalmology and Visual Sciences, The
University of Chicago, Chicago, IL, USA
- The College, The University of Chicago, Chicago, IL,
USA
| | - Ashtyn Dixon
- Department of Ophthalmology and Visual Sciences, The
University of Chicago, Chicago, IL, USA
| | - Xuan Li
- Rush University Medical School/Rush University Medical
Center, Chicago, IL, USA
| | - Ian Begeman
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
- Department of Ophthalmology and Visual Sciences, The
University of Chicago, Chicago, IL, USA
| | - Sharon Heichman
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
- Department of Ophthalmology and Visual Sciences, The
University of Chicago, Chicago, IL, USA
| | - Joseph Lykins
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
- Department of Ophthalmology and Visual Sciences, The
University of Chicago, Chicago, IL, USA
| | - Delba Villalobos-Cerrud
- Instituto de Investigaciones Científicas y Servicios
de Alta Tecnología AIP (INDICASAT-AIP), Panama City, Panama
| | - Lorena Fabrega
- Instituto de Investigaciones Científicas y Servicios
de Alta Tecnología AIP (INDICASAT-AIP), Panama City, Panama
| | - José Luis Sanchez Montalvo
- Department of Ophthalmology and Visual Sciences, The
University of Chicago, Chicago, IL, USA
- The Global Health Center, The University of Chicago,
Chicago, IL, USA
| | - Connie Mendivil
- Instituto de Investigaciones Científicas y Servicios
de Alta Tecnología AIP (INDICASAT-AIP), Panama City, Panama
| | - Mario R. Quijada
- Instituto de Investigaciones Científicas y Servicios
de Alta Tecnología AIP (INDICASAT-AIP), Panama City, Panama
| | - Silvia Fernández-Pirla
- Toxoplasmosis Programs and Initiatives in Panamá,
Panama City, Panama
- Instituto de Investigaciones Científicas y Servicios
de Alta Tecnología AIP (INDICASAT-AIP), Panama City, Panama
- Academia Interamericana de Panamá, Panama City,
Panama
- Hospital Santo Tomás, Panama City, Panama
| | - Valli de La Guardia
- Toxoplasmosis Programs and Initiatives in Panamá,
Panama City, Panama
- Instituto de Investigaciones Científicas y Servicios
de Alta Tecnología AIP (INDICASAT-AIP), Panama City, Panama
- Hospital Santo Tomás, Panama City, Panama
- Hospital San Miguel de Arcangel, Ciudad de Panama,
Panama
| | - Digna Wong
- Instituto de Investigaciones Científicas y Servicios
de Alta Tecnología AIP (INDICASAT-AIP), Panama City, Panama
| | - Mayrene Ladrón de Guevara
- Instituto de Investigaciones Científicas y Servicios
de Alta Tecnología AIP (INDICASAT-AIP), Panama City, Panama
- Hospital Santo Tomás, Panama City, Panama
| | | | | | - Anabel García
- Instituto de Investigaciones Científicas y Servicios
de Alta Tecnología AIP (INDICASAT-AIP), Panama City, Panama
| | | | - Maria Theresa Moreno de Saez
- Department of Pediatrics Infectious Diseases/Department of
Neonatology, Hospital del Niño Doctor José Renán Esquivel,
Panama City, Panama
| | - Michael Politis
- Toxoplasmosis Programs and Initiatives in Panamá,
Panama City, Panama
| | - Stephanie Ross
- Rush University Medical School/Rush University Medical
Center, Chicago, IL, USA
| | - Mimansa Dogra
- The Global Health Center, The University of Chicago,
Chicago, IL, USA
| | - Vishan Dhamsania
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
- The Global Health Center, The University of Chicago,
Chicago, IL, USA
- Capstone Program, Global Health Center, The University of
Chicago, Chicago, IL, USA
| | - Nicholas Graves
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
- The Global Health Center, The University of Chicago,
Chicago, IL, USA
- Capstone Program, Global Health Center, The University of
Chicago, Chicago, IL, USA
| | - Marci Kirchberg
- Capstone Program, Global Health Center, The University of
Chicago, Chicago, IL, USA
- Harris School of Public Policy, The University of
Chicago, Chicago, IL, USA
| | - Kopal Mathur
- Capstone Program, Global Health Center, The University of
Chicago, Chicago, IL, USA
- Harris School of Public Policy, The University of
Chicago, Chicago, IL, USA
| | - Ashley Aue
- The Global Health Center, The University of Chicago,
Chicago, IL, USA
- Harris School of Public Policy, The University of
Chicago, Chicago, IL, USA
| | - Carlos M. Restrepo
- Instituto de Investigaciones Científicas y Servicios
de Alta Tecnología AIP (INDICASAT-AIP), Panama City, Panama
| | - Alejandro Llanes
- Instituto de Investigaciones Científicas y Servicios
de Alta Tecnología AIP (INDICASAT-AIP), Panama City, Panama
| | - German Guzman
- Instituto de Investigaciones Científicas y Servicios
de Alta Tecnología AIP (INDICASAT-AIP), Panama City, Panama
| | - Arturo Rebellon
- Sanofi Aventis de Panamá S.A., University of South
Florida, Panama City, Panama
| | - Kenneth Boyer
- Rush University Medical School/Rush University Medical
Center, Chicago, IL, USA
| | - Peter Heydemann
- Rush University Medical School/Rush University Medical
Center, Chicago, IL, USA
| | - A. Gwendolyn Noble
- Department of Ophthalmology and Visual Sciences, The
University of Chicago, Chicago, IL, USA
- Northwestern University Feinberg School of Medicine,
Chicago, IL, USA
| | - Charles Swisher
- Department of Ophthalmology and Visual Sciences, The
University of Chicago, Chicago, IL, USA
- Northwestern University Feinberg School of Medicine,
Chicago, IL, USA
| | - Peter Rabiah
- Department of Ophthalmology and Visual Sciences, The
University of Chicago, Chicago, IL, USA
- NorthShore Evanston Hospital, Evanston, IL, USA
| | - Shawn Withers
- Department of Ophthalmology and Visual Sciences, The
University of Chicago, Chicago, IL, USA
| | - Teri Hull
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
| | - David Frim
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
| | - David McLone
- Northwestern University Feinberg School of Medicine,
Chicago, IL, USA
| | - Chunlei Su
- Department of Microbiology, The University of Tennessee,
Knoxville, TN, USA
| | - Michael Blair
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
- Department of Ophthalmology and Visual Sciences, The
University of Chicago, Chicago, IL, USA
| | - Paul Latkany
- Department of Ophthalmology and Visual Sciences, The
University of Chicago, Chicago, IL, USA
| | - Ernest Mui
- Department of Ophthalmology and Visual Sciences, The
University of Chicago, Chicago, IL, USA
| | | | - Alcibiades Villareal
- Instituto de Investigaciones Científicas y Servicios
de Alta Tecnología AIP (INDICASAT-AIP), Panama City, Panama
| | - Ambar Perez
- Instituto de Investigaciones Científicas y Servicios
de Alta Tecnología AIP (INDICASAT-AIP), Panama City, Panama
| | | | | | | | - Morgan Ramirez
- The College, The University of Chicago, Chicago, IL,
USA
| | - Cy Chittenden
- The College, The University of Chicago, Chicago, IL,
USA
| | - Edward Wang
- The College, The University of Chicago, Chicago, IL,
USA
| | | | - Juliana Muñoz-Ortiz
- Grupo de Investigación en Neurociencias,
Universidad del Rosario, Bogotá, Colombia
| | | | | | | | - Guillermo Padrieu
- Toxoplasmosis Programs and Initiatives in Panamá,
Panama City, Panama
- Instituto de Investigaciones Científicas y Servicios
de Alta Tecnología AIP (INDICASAT-AIP), Panama City, Panama
- Grupo de Investigación en Neurociencias,
Universidad del Rosario, Bogotá, Colombia
| | | | | | | | | | | | | | - Dan L. Nicolae
- Department of Statistics, The University of Chicago,
Chicago, IL, USA
| | - Andrey Rzhetsky
- Institute for Genomics and Systems Biology, The University
of Chicago, Chicago, IL, USA
| | - Nancy Roizen
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
| | | | - Larry Sawers
- Department of Economics, American University, D,
Washington .C, USA
| | - Francois Peyron
- Institut des agents infectieux, Hôpital de la
Croix-Rousse, Lyon, France
| | - Martine Wallon
- Institut des agents infectieux, Hôpital de la
Croix-Rousse, Lyon, France
| | - Emanuelle Chapey
- Institut des agents infectieux, Hôpital de la
Croix-Rousse, Lyon, France
| | - Pauline Levigne
- Institut des agents infectieux, Hôpital de la
Croix-Rousse, Lyon, France
| | | | | | - Jose Montoya
- Remington Specialty Laboratory, Palo Alto, CA, USA
| | - Cindy Press
- Remington Specialty Laboratory, Palo Alto, CA, USA
| | | | - Despina Contopoulos-Ioannidis
- Department of Pediatrics, Division of Infectious
Diseases, Stanford University College of Medicine, Stanford, CA, USA
| | - Yvonne Maldonado
- Department of Pediatrics, Division of Infectious
Diseases, Stanford University College of Medicine, Stanford, CA, USA
| | | | - Carlos Gomez
- Department of Pediatrics, Division of Infectious
Diseases, Stanford University College of Medicine, Stanford, CA, USA
| | - Kelsey Wheeler
- Department of Ophthalmology and Visual Sciences, The
University of Chicago, Chicago, IL, USA
- The College, The University of Chicago, Chicago, IL,
USA
| | - Samantha Zehar
- Northwestern University Feinberg School of Medicine,
Chicago, IL, USA
| | - James McAuley
- Department of Ophthalmology and Visual Sciences, The
University of Chicago, Chicago, IL, USA
| | | | - Sandrine Houze
- Laboratory of Parasitologie, Bichat-Claude Bernard
Hopital, Paris, France
| | - Sylvie Abraham
- Laboratory of Parasitologie, Bichat-Claude Bernard
Hopital, Paris, France
| | | | - Vera Tesic
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
| | - Kathleen Beavis
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
| | - Ana Abeleda
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
| | - Mari Sautter
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
- Department of Ophthalmology and Visual Sciences, The
University of Chicago, Chicago, IL, USA
| | | | | | - Fatima Amarir
- Faculty of Sciences Ain Chock, University Hassan II,
Casablanca, Morocco
| | - Kamal El Bissati
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
- INH, Rabat, Morocco
| | - Ellen Holfels
- Department of Ophthalmology and Visual Sciences, The
University of Chicago, Chicago, IL, USA
| | - Richard Penn
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
| | - William Cohen
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
- Department of Ophthalmology and Visual Sciences, The
University of Chicago, Chicago, IL, USA
- The College, The University of Chicago, Chicago, IL,
USA
| | | | - Gabrielle Britton
- Instituto de Investigaciones Científicas y Servicios
de Alta Tecnología AIP (INDICASAT-AIP), Panama City, Panama
- Sistema Nacional de investigadores de Panamá
(SNI), Panama City, Panama
| | - Jorge Motta
- Sistema Nacional de investigadores de Panamá
(SNI), Panama City, Panama
- Secretaría Nacional de Ciencia, Tecnología
e Innovación (SENACYT), Panama City, Panama
| | - Eduardo Ortega-Barria
- Sistema Nacional de investigadores de Panamá
(SNI), Panama City, Panama
- Secretaría Nacional de Ciencia, Tecnología
e Innovación (SENACYT), Panama City, Panama
- GSK Vaccines, Panama City, Panama
| | - Isabel Luz Romero
- Secretaría Nacional de Ciencia, Tecnología
e Innovación (SENACYT), Panama City, Panama
| | - Paul Meier
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
| | - Michael Grigg
- Molecular Parasitology Section, Laboratory of Parasitic
Diseases, National Institutes of Health, NIAID, Bethesda, MD, USA
| | - Jorge Gómez-Marín
- Universidad del Quindío, Armenia, Colombia
- Jorge Gómez-Marín,
, Jagannatha Rao Kosagisharaf,
, Xavier Sáez Llorens,
, Osvaldo Reyes,
, Rima McLeod,
| | - Jagannatha Rao Kosagisharaf
- Instituto de Investigaciones Científicas y Servicios
de Alta Tecnología AIP (INDICASAT-AIP), Panama City, Panama
- Sistema Nacional de investigadores de Panamá
(SNI), Panama City, Panama
- Jorge Gómez-Marín,
, Jagannatha Rao Kosagisharaf,
, Xavier Sáez Llorens,
, Osvaldo Reyes,
, Rima McLeod,
| | - Xavier Sáez Llorens
- Department of Pediatrics Infectious Diseases/Department of
Neonatology, Hospital del Niño Doctor José Renán Esquivel,
Panama City, Panama
- Sistema Nacional de investigadores de Panamá
(SNI), Panama City, Panama
- Jorge Gómez-Marín,
, Jagannatha Rao Kosagisharaf,
, Xavier Sáez Llorens,
, Osvaldo Reyes,
, Rima McLeod,
| | - Osvaldo Reyes
- Universidad de Panamá, Panama City, Panama
- Hospital Santo Tomás, Panama City, Panama
- Sistema Nacional de investigadores de Panamá
(SNI), Panama City, Panama
- Jorge Gómez-Marín,
, Jagannatha Rao Kosagisharaf,
, Xavier Sáez Llorens,
, Osvaldo Reyes,
, Rima McLeod,
| | - Rima McLeod
- Toxoplasmosis Programs and Initiatives in Panamá,
Panama City, Panama
- Institute for Genomics and Systems Biology, The University
of Chicago, Chicago, IL, USA
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
- Department of Ophthalmology and Visual Sciences, The
University of Chicago, Chicago, IL, USA
- The College, The University of Chicago, Chicago, IL,
USA
- The Global Health Center, The University of Chicago,
Chicago, IL, USA
- Toxoplasmosis Center, The University of Chicago, and
Toxoplasmosis Research Institute, Chicago, IL, USA
- Department of Pediatrics (Infectious Diseases), The
University of Chicago, Chicago, IL, USA
- Jorge Gómez-Marín,
, Jagannatha Rao Kosagisharaf,
, Xavier Sáez Llorens,
, Osvaldo Reyes,
, Rima McLeod,
| |
Collapse
|
5
|
Cua J, Crespo E, Phelps S, Ramirez R, Roque-Torres G, Oyoyo U, Kwon SR. Tooth Color Change and Erosion: Hydrogen Peroxide Versus Non-peroxide Whitening Strips. Oper Dent 2022; 47:301-308. [PMID: 35584321 DOI: 10.2341/20-302-l] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 04/18/2021] [Indexed: 11/23/2022]
Abstract
AIM The study evaluated the efficacy and potential erosion of non-peroxide strips compared to hydrogen peroxide (HP) whitening strips (WSs). METHODS Color evaluation samples (N=64) were distributed into four groups and treated according to manufacturer's directions. NC: Negative control treated with water; BT: Non-peroxide Brilliant Dissolving Strips; FM: Non-peroxide Fancymay Teeth WSs; WS: Crest 3D Brilliance HP White Strips. A contact-type spectrophotometer was used to measure color at baseline (T1), 1-day posttreatment (T2), and 1-week posttreatment (T3). Teeth were cut to a rectangular block for micro-CT erosion assessment. The samples (N=30) were divided into five groups. In addition to the four groups for color assessment, a positive control (PC) treated with 0.25% citric acid was added. The samples were scanned, reconstructed, and measured for erosion depth using a micro-CT analysis program software. Kruskal-Wallis test was used to determine differences in color change and erosion depth among the groups. Tests of hypotheses were two-sided with an alpha level of 0.05. RESULTS The mean ΔE*ab at 1-day/1-week posttreatment were 2.4/2.5, 2.8/2.9, 2.8/3.2, and 8.6/11.0 for NC, BT, FM, and WS, respectively. There was a statistically significant difference for ΔE*ab at 1-day and 1-week posttreatment (p<0.001). Group WS had the highest color change, while the other three groups did not differ from each other (p>0.05). Mean erosion depths in microns were 0.52, 0.58, 0.42, 0.49, and 29.55 for NC, BT, FM, WS, and PC, respectively. There was a statistically significant difference among the groups (p=0.004). Group PC had the greatest erosion, while the other groups had negligible erosion that did not differ from each other (p>0.05). CONCLUSION Peroxide WSs had superior whitening efficacy compared to non-peroxide strips. None of the tested products compromised tooth structure integrity through enamel erosion.
Collapse
Affiliation(s)
- J Cua
- John Cua, RDH, Loma Linda University School of Dentistry, Loma Linda, CA, USA
| | - E Crespo
- Elisabeth Crespo, RDH, Loma Linda University School of Dentistry, Loma Linda, CA, USA
| | - S Phelps
- Sarah Phelps, RDH, Loma Linda University School of Dentistry, Loma Linda, CA, USA
| | - R Ramirez
- Rachel Ramirez, RDH, Loma Linda University School of Dentistry, Loma Linda, CA, USA
| | - G Roque-Torres
- Gina Roque-Torres, DDS, MS, PhD, assistant professor, Center for Dental Research, Loma Linda University School of Dentistry, Loma Linda, CA, USA
| | - U Oyoyo
- Udochukwu Oyoyo, MPH, assistant professor, Dental Education Services, Loma Linda University School of Dentistry, Loma Linda, CA, USA
| | - S R Kwon
- *So Ran Kwon, DDS, MS, PhD, MS, professor & director of Student Research Program, Division of General Dentistry, Loma Linda University School of Dentistry, Loma Linda, CA, USA
| |
Collapse
|
6
|
Smeltzer M, Bunn B, Choi Y, Coate L, Corona-Cruz J, Drilon A, Duma N, Edelman M, Fidler M, Gadgeel S, Goto Y, Herbst R, Hesdorffer M, Higgins K, Labdi B, Leal T, Liu S, Mazotti J, Novello S, Patel S, Popat S, Ramirez R, Reckamp K, Reguart N, Soo R, Tan A, Wolf J, Yano S, Stiles B, Baird A. OA17.04 The Global Impact of COVID-19 on Telehealth and Care for Persons With Thoracic Cancers. J Thorac Oncol 2021. [PMCID: PMC8523155 DOI: 10.1016/j.jtho.2021.08.093] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
7
|
Thomas K, Smith C, Marsala A, Boudreaux J, Thiagarajan R, Ramirez R. P49.04 The use of Stereotactic Body Radiotherapy in Pulmonary Carcinoid Tumors: A Single Institution Retrospective Review. J Thorac Oncol 2021. [DOI: 10.1016/j.jtho.2021.01.898] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
8
|
Riddell EA, Iknayan KJ, Hargrove L, Tremor S, Patton JL, Ramirez R, Wolf BO, Beissinger SR. Exposure to climate change drives stability or collapse of desert mammal and bird communities. Science 2021; 371:633-636. [DOI: 10.1126/science.abd4605] [Citation(s) in RCA: 47] [Impact Index Per Article: 15.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/23/2020] [Accepted: 01/05/2021] [Indexed: 12/15/2022]
Affiliation(s)
- E. A. Riddell
- Museum of Vertebrate Zoology, University of California, Berkeley, CA 94720, USA
- Department of Ecology, Evolution, and Organismal Biology, Iowa State University, Ames, IA 50010, USA
| | - K. J. Iknayan
- Department of Environmental Science, Policy, and Management, University of California, Berkeley, CA 94720, USA
- San Francisco Estuary Institute, Richmond, CA 94804, USA
| | - L. Hargrove
- Department of Birds and Mammals, San Diego Natural History Museum, San Diego, CA 92101, USA
| | - S. Tremor
- Department of Birds and Mammals, San Diego Natural History Museum, San Diego, CA 92101, USA
| | - J. L. Patton
- Museum of Vertebrate Zoology, University of California, Berkeley, CA 94720, USA
| | - R. Ramirez
- Department of Biology, University of New Mexico, Albuquerque, NM 87131, USA
| | - B. O. Wolf
- Department of Biology, University of New Mexico, Albuquerque, NM 87131, USA
| | - S. R. Beissinger
- Museum of Vertebrate Zoology, University of California, Berkeley, CA 94720, USA
- Department of Environmental Science, Policy, and Management, University of California, Berkeley, CA 94720, USA
| |
Collapse
|
9
|
Freire RM, Palma JL, Michea S, Ramirez R, Baltazar SE, Denardin JC. Coercivity dependence of cation distribution in Co-based spinel: correlating theory and experiments. Inorg Chem Front 2021. [DOI: 10.1039/d0qi01129k] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Abstract
The inversion degree of a spinel-type nanomaterial is an essential parameter to understand the magnetic and electronic properties of ferrites. By micromagnetic simulations, we were able to connect DFT calculations and experiments for CoFe2O4 NPs.
Collapse
Affiliation(s)
- R. M. Freire
- Center for the Development of Nanoscience and Nanotechnology
- CEDENNA
- Santiago
- Chile
- Instituto de Ciencias Químicas Aplicadas
| | - J. L. Palma
- Center for the Development of Nanoscience and Nanotechnology
- CEDENNA
- Santiago
- Chile
- Escuela de Ingeniería
| | - S. Michea
- Center for the Development of Nanoscience and Nanotechnology
- CEDENNA
- Santiago
- Chile
- Instituto de Ciencias Químicas Aplicadas
| | - R. Ramirez
- Center for the Development of Nanoscience and Nanotechnology
- CEDENNA
- Santiago
- Chile
| | - S. E. Baltazar
- Center for the Development of Nanoscience and Nanotechnology
- CEDENNA
- Santiago
- Chile
- Departamento de Física
| | - J. C. Denardin
- Center for the Development of Nanoscience and Nanotechnology
- CEDENNA
- Santiago
- Chile
- Departamento de Física
| |
Collapse
|
10
|
Bhatia K, Ramirez R, Narasimhan B, Walsh S, Sud K, Uberoi G, Argulian E. Prognostic role of positron emission tomography in patients with known or suspected cardiac sarcoidosis. a systematic review and meta-analysis. Eur Heart J 2020. [DOI: 10.1093/ehjci/ehaa946.0286] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
Sarcoidosis is a chronic inflammatory disorder of unclear etiology, characterized by the presence of non-caseating granulomas. Cardiac involvement occurs in upto 27 percent of patients, manifesting as atrioventricular blocks, ventricular arrhythmia or sudden cardiac death. Current guidelines cite insufficient evidence for the prognostic utility of positron emission tomography (PET) in patients with cardiac sarcoidosis. Thus, we performed a systematic review and meta-analysis of published studies to ascertain the prognostic significance of PET imaging in patients with suspected or diagnosed cardiac sarcoidosis.
Purpose
To review current literature and determine if PET has prognostic utility in patients with known or suspected cardiac sarcoidosis
Methods
We performed a comprehensive literature search of electronic databases (Embase, Medline and Web of Science) using MeSH terms and keywords for sarcoidosis and PET from inception through December 2019. Studies were eligible if they included patients with known and/or suspected cardiac sarcoidosis undergoing evaluation by PET with or without perfusion imaging and reported clinical events of interest. An abnormal PET study was defined as the presence of focal or focal-on-diffuse uptake of 18- fluorodeoxyglucose (18-FDG) by visual analysis. In studies with perfusion imaging, patients with only perfusion defects were excluded. The primary outcome of interest was a composite of major adverse cardiac events (MACE), including sustained ventricular tachycardia, sudden cardiac death. Secondary analysis studied association of MACE with focal right ventricular (RV) uptake in patients with an abnormal PET study. Pooled odds ratio (OR) and 95% confidence interval (CI) were calculated using a random-effects model. Heterogeneity of results among the studies was assessed using the Higgins I2 value.
Results
Out of a total of 1645 citations, 40 were selected for full-text review. Five studies were included in the final analysis with a total of 465 patients. mean follow-up was 2.3 years. Three of the five studies also reported frequency of abnormal RV uptake of 18-FDG. Patients with abnormal 18-FDG uptake on visual assessment had higher odds of MACE (OR 3.12, CI 1.9–5.01, p<0.00001), compared to known or suspected cardiac sarcoid patients with normal PET studies. Heterogeneity among studies was low (I2 = 0). In patients with an abnormal PET study, abnormal focal RV uptake of 18-FDG was associated with higher odds of MACE (OR 5.24, CI 1.1–25.1, p=0.04), with moderate heterogeneity among studies (I2=41).
Conclusion
In patients undergoing PET imaging for known or suspected cardiac sarcoidosis, abnormal metabolism on visual analysis is associated with increased risk of MACE. Furthermore, focal RV uptake further increases the risk of MACE in patients with abnormal PET imaging. Thus, PET imaging can serve as a tool to risk stratify patients with known or suspected cardiac sarcoidosis.
Forrest Plots
Funding Acknowledgement
Type of funding source: None
Collapse
Affiliation(s)
- K Bhatia
- Mount Sinai St Luke's and Mount Sinai West, New York, United States of America
| | - R Ramirez
- Mount Sinai St Luke's and Mount Sinai West, New York, United States of America
| | - B Narasimhan
- Mount Sinai St Luke's and Mount Sinai West, New York, United States of America
| | - S Walsh
- Icahn School of Medicine at Mount Sinai, New York, United States of America
| | - K Sud
- Mount Sinai St Luke's and Mount Sinai West, New York, United States of America
| | - G Uberoi
- Mount Sinai St Luke's and Mount Sinai West, New York, United States of America
| | - E Argulian
- Mount Sinai St Luke's and Mount Sinai West, New York, United States of America
| |
Collapse
|
11
|
Gallardo-Alvarado L, de León DC, Salcedo-Hernández R, Ramirez R, Barquet-Muñoz S, Isla-Ortiz D, Rivera-Buendia F, Perez-Montiel D, Quintanilla MP, Del Real S. Hemoglobin levels during treatment as prognostic factors in locally advanced cervical cancer in Mexican patients. Gynecol Oncol 2020. [DOI: 10.1016/j.ygyno.2020.05.307] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
12
|
de León DC, Gallardo-Alvarado L, Salcedo-Hernández R, Perez-Montiel D, Ramirez R, Barquet-Muñoz S, Quintanilla MP, Rivera-Buendia F, Del Real S. Neoadjuvant chemotherapy in advanced epithelial ovarian cancer: Is the number of preoperative cycles important? Gynecol Oncol 2020. [DOI: 10.1016/j.ygyno.2020.05.145] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
13
|
de León DC, Gallardo-Alvarado L, Ramirez R, Perez-Montiel D, Salcedo-Hernández R, Barquet-Muñoz S, Quintanilla MP, Rivera-Buendia F, Del Real S. Tumor histology as prognostic factor in locally advanced cervical cancer in a reference center. Gynecol Oncol 2020. [DOI: 10.1016/j.ygyno.2020.05.267] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
14
|
Gallardo-Alvarado L, de León DC, Ramirez R, Barquet-Muñoz S, Salcedo-Hernández R, Perez-Montiel D, Rivera-Buendia F, Del Real S, Quintanilla MP, Perez-Marquez J. Do the young have a worse prognosis in comparison to the geriatric patients with locally advanced cervical cancer? Gynecol Oncol 2020. [DOI: 10.1016/j.ygyno.2020.05.294] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
15
|
de León DC, Gallardo-Alvarado L, Ramirez R, Perez-Montiel D, Quintanilla MP, Del Real S. Locally advanced cervical cancer: Are there differences between young and geriatric patients? Gynecol Oncol 2020. [DOI: 10.1016/j.ygyno.2020.05.664] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
16
|
Gutierrez-Villamil C, Peix A, Orellana P, Berrocal I, Ramirez R, Estrada-Lobato E, Paez D. Impact of International Atomic Energy Agency support to the development of nuclear cardiology in low-and-middle-income countries: Case of Latin America and the Caribbean. J Nucl Cardiol 2019; 26:2048-2054. [PMID: 31286416 PMCID: PMC6908563 DOI: 10.1007/s12350-019-01805-w] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/08/2019] [Accepted: 06/17/2019] [Indexed: 11/26/2022]
Abstract
Cardiovascular diseases (CVDs) are the leading cause of death in Latin America and the Caribbean (LAC) region as well as worldwide. Lifestyle, nutritional habits and the upsurge of obesity have contributed to the increase in the prevalence of CVDs in the region. The role of nuclear cardiology in the management of patients with CVDs is well established. Particularly, myocardial perfusion imaging is widely used in LAC countries and has been increasingly integrated into the healthcare systems in the region for the diagnosis of coronary artery disease, risk stratification and to guide patient management. In its role to support countries around the world to address their health needs through the peaceful applications of nuclear techniques, the International Atomic Energy Agency (IAEA) has provided assistance to the LAC region for the establishment and strengthening of the nuclear cardiology practice. To that extent, the IAEA provides support in building capacities of multidisciplinary teams of professionals, the provision of medical equipment and the promotion of communication and exchange of knowledge among the different stakeholders. In addition, the IAEA encourages the participation of nuclear medicine centers in international multi-center research studies. In this paper, we present some of the projects through which the IAEA has supported the LAC region, including regional technical cooperation projects and coordinated research projects related to cardiology within the current multimodality approach to cardiac imaging.
Collapse
Affiliation(s)
- C Gutierrez-Villamil
- Servicio de Medicina Nuclear, Fundación Cardioinfantil - Instituto de Cardiología, Bogotá, Colombia
- Escuela de Medicina y Ciencias de la Salud, Universidad del Rosario, Bogotá, Colombia
| | - A Peix
- Nuclear Medicine Department, Institute of Cardiology, 17 No. 702, Vedado, CP 10 400, Havana, Cuba.
| | - P Orellana
- Nuclear Medicine Unit, Radiology Department, Pontificia Universidad Catolica de Chile, Santiago, Chile
| | - I Berrocal
- Hospital San Juan de Dios, San Jose, Costa Rica
| | - R Ramirez
- Technical Cooperation Section for Latin America and the Caribbean, International Atomic Energy Agency, Vienna, Austria
| | - E Estrada-Lobato
- Nuclear Medicine and Diagnostic Imaging Section, International Atomic Energy Agency, Vienna, Austria
| | - D Paez
- Nuclear Medicine and Diagnostic Imaging Section, International Atomic Energy Agency, Vienna, Austria
| |
Collapse
|
17
|
Gnatiuc L, Alegre-Diaz J, Garcilazo-Avila A, Ramirez R, Gonzales-Carballo C, Solano-Sanchez M, Chiquete E, Wade R, Clarke R, Herrington WG, Collins R, Peto R, Tapia-Conyer R, Kuri-Morales P, Emberson J. P3824Body composition and mortality from vascular or metabolic causes among 150,000 participants in the Mexico City Prospective Study. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz745.0666] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Background
Higher body-mass index is associated with increased mortality from vascular disease, renal disease and other metabolic causes. However, body mass reflects both fat and lean mass, which may have very different effects on risk. We investigated the individual and joint relevance of fat and lean mass to mortality from these causes, using data from the Mexico City Prospective Study.
Methods
Between 1998 and 2004, 150,000 adults from Mexico City were recruited into a prospective study and tracked for cause-specific mortality for 14 years. Fat and lean mass at recruitment were predicted using Mexican-specific anthropometric equations, validated in a subset of participants with additional bio-impedance measures. Cox regression was used to assess the relevance of fat and lean mass at recruitment to mortality from a vascular, renal, or other metabolic cause at ages 35–74 years. Analyses were adjusted for age at risk, sex, residential district, education, recreational physical activity, smoking and alcohol consumption. To avoid reverse causality, analyses excluded those with diabetes or other chronic diseases at recruitment, and deaths in the first 5 years of follow-up. Mortality rate ratios (RRs) relate to the differences per SD of the usual values of various factors or the differences between the top tenth and bottom fifth of the values.
Results
Among 112,923 participants aged 35–74 years, mean (SD) fat mass in men and women was 22.0 (6.4) kgs and 29.4 (7.8) kgs respectively, while mean (SD) lean mass was 54.9 (7.2) kgs and 39.2 (5.0) kgs respectively. In both men and women, equation-predicted fat and lean mass closely matched the bio-impedance values (all r>0.86). Both fat and lean mass were positively and approximately log-linearly associated with mortality from a vascular or metabolic cause. However, the association of lean mass with mortality was more than accounted for by the correlation of lean with fat mass. Hence, after adjustment for fat mass, lean mass was inversely associated with risk. For a given amount of fat mass, the RR for vascular/metabolic mortality comparing those in the top tenth versus bottom fifth of the predicted lean mass was 0.35 (95% CI 0.24–0.52). Conversely, for a given amount of lean mass, the RR comparing those in the top tenth versus bottom fifth of the predicted fat mass was 4.06 (3.06–5.39). The RRs associated with each SD higher fat mass (1.51, 1.40–1.63) or lean mass (0.79, 0.73–0.86) appeared to be little affected by age, sex, or levels of other confounders, and were broadly similar for the major vascular, renal, and other metabolic mortality. The height-adjusted RRs were 1.41 (1.30–1.53) for fat mass and 0.91 (0.82–1.00) for lean mass.
Conclusions
In this Mexican cohort, predicted fat and lean mass had opposing effects on vascular and other metabolic deaths, with no evidence of any thresholds throughout the ranges studied.
Collapse
Affiliation(s)
- L Gnatiuc
- University of Oxford, CTSU, Nuffield Department of Population Health,, Oxford, United Kingdom
| | - J Alegre-Diaz
- National Autonomous University of Mexico, School of Medicine, Mexico City, Mexico
| | - A Garcilazo-Avila
- National Autonomous University of Mexico, School of Medicine, Mexico City, Mexico
| | - R Ramirez
- National Autonomous University of Mexico, School of Medicine, Mexico City, Mexico
| | - C Gonzales-Carballo
- National Autonomous University of Mexico, School of Medicine, Mexico City, Mexico
| | - M Solano-Sanchez
- National Autonomous University of Mexico, School of Medicine, Mexico City, Mexico
| | - E Chiquete
- National Autonomous University of Mexico, School of Medicine, Mexico City, Mexico
| | - R Wade
- University of Oxford, MRC Population Health Research Unit; Nuffield Department of Population Health, Oxford, United Kingdom
| | - R Clarke
- University of Oxford, CTSU, Nuffield Department of Population Health,, Oxford, United Kingdom
| | - W G Herrington
- University of Oxford, MRC Population Health Research Unit; Nuffield Department of Population Health, Oxford, United Kingdom
| | - R Collins
- University of Oxford, CTSU, Nuffield Department of Population Health,, Oxford, United Kingdom
| | - R Peto
- University of Oxford, CTSU, Nuffield Department of Population Health,, Oxford, United Kingdom
| | - R Tapia-Conyer
- National Autonomous University of Mexico, School of Medicine, Mexico City, Mexico
| | - P Kuri-Morales
- National Autonomous University of Mexico, School of Medicine, Mexico City, Mexico
| | - J Emberson
- University of Oxford, MRC Population Health Research Unit; Nuffield Department of Population Health, Oxford, United Kingdom
| |
Collapse
|
18
|
Ramirez R, Matrana M, Satti S, Griffin R, Voros B, Mohammed A, Thiagarajan R, Boudreaux J, Woltering E. EP1.12-18 NET-001: A Phase II Study of ABI-009 in Metastatic Neuroendocrine Tumors of the Lung or Gastroenteropancreatic System. J Thorac Oncol 2019. [DOI: 10.1016/j.jtho.2019.08.2263] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
19
|
Pomares C, Devillard S, Holmes TH, Olariu TR, Press CJ, Ramirez R, Talucod J, Estran R, Su C, Dubey JP, Ajzenberg D, Montoya JG. Genetic Characterization of Toxoplasma gondii DNA Samples Isolated From Humans Living in North America: An Unexpected High Prevalence of Atypical Genotypes. J Infect Dis 2019; 218:1783-1791. [PMID: 29982713 DOI: 10.1093/infdis/jiy375] [Citation(s) in RCA: 36] [Impact Index Per Article: 7.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/03/2018] [Accepted: 06/29/2018] [Indexed: 11/12/2022] Open
Abstract
Background Whereas in Europe most of Toxoplasma gondii genotypes belong to the type II lineage, in Latin America, type II is rare and atypical strains predominate. In North America, data on T. gondii genotypes in humans are scarce. Methods In this study, T. gondii DNA samples from 67 patients with diagnosed toxoplasmosis in the United States were available for genotyping. Discriminant analysis of principal components was used to infer each atypical genotype to a geographic area where patients were probably infected. Associations between genotype, disease severity, immune status, and geographic region were also estimated. Results Of 67 DNA samples, 41 were successfully genotyped: 18 (43.9%) and 5 (12.2%) were characterized as types II and III, respectively. The remaining 18 genotypes (43.9%) were atypical and were assigned to a geographic area. Ten genotypes originated from Latin America, 7 from North America, and 1 from Asia (China). In North America, unlike in Europe, T. gondii atypical genotypes are common in humans and, unlike in Latin America, type II strains are still present with significant frequency. Conclusions Clinicians should be aware that atypical genotypes are common in North America and have been associated with severe ocular and systemic disease and unusual presentations of toxoplasmosis in immunocompetent patients.
Collapse
Affiliation(s)
- Christelle Pomares
- Palo Alto Medical Foundation Toxoplasma Serology Laboratory, National Reference Center for the Study and Diagnosis of Toxoplasmosis, California.,Division of Infectious Diseases, Department of Medicine, California.,Institut national de la santé et de la recherche médicale, U1065, Centre Méditerranéen de Médecine Moléculaire, Virulence Microbienne et Signalisation Inflammatoire-Université de la Côte d'Azur, Faculté de Médecine.,Parasitologie-Mycologie, Centre Hospitalier Universitaire l'Archet, Nice
| | - Sébastien Devillard
- Université Lyon, Université Claude Bernard Lyon 1, Centre national de la recherche scientifique, Laboratoire de Biométrie et Biologie Evolutive, Villeurbanne
| | - Tyson H Holmes
- Division of Infectious Diseases, Department of Medicine, California.,Stanford University Human Immune Monitoring Center, Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, California
| | | | - Cynthia J Press
- Palo Alto Medical Foundation Toxoplasma Serology Laboratory, National Reference Center for the Study and Diagnosis of Toxoplasmosis, California
| | - Raymund Ramirez
- Palo Alto Medical Foundation Toxoplasma Serology Laboratory, National Reference Center for the Study and Diagnosis of Toxoplasmosis, California
| | - Jeanne Talucod
- Palo Alto Medical Foundation Toxoplasma Serology Laboratory, National Reference Center for the Study and Diagnosis of Toxoplasmosis, California
| | - Remy Estran
- Ecole Supérieure de Commerce de Paris Europe, Paris
| | - Chunlei Su
- Department of Microbiology, University of Tennessee, Knoxville
| | - Jitender P Dubey
- United States Department of Agriculture, Agricultural Research Service, Beltsville Agricultural Research Center, Animal Parasitic Diseases Laboratory, Maryland
| | - Daniel Ajzenberg
- Institut national de la santé et de la recherche médicale, University of Limoges, Centre Hospitalier Universitaire Limoges, Unité Mixte de Recherche_S, Tropical Neuroepidemiology, Institute of Neuroepidemiology and Tropical Neurology, Limoges, France
| | - Jose G Montoya
- Palo Alto Medical Foundation Toxoplasma Serology Laboratory, National Reference Center for the Study and Diagnosis of Toxoplasmosis, California.,Division of Infectious Diseases, Department of Medicine, California
| |
Collapse
|
20
|
Li X, Pomares C, Peyron F, Press CJ, Ramirez R, Geraldine G, Cannavo I, Chapey E, Levigne P, Wallon M, Montoya JG, Dai H. Plasmonic gold chips for the diagnosis of Toxoplasma gondii, CMV, and rubella infections using saliva with serum detection precision. Eur J Clin Microbiol Infect Dis 2019; 38:883-890. [PMID: 30701339 DOI: 10.1007/s10096-019-03487-1] [Citation(s) in RCA: 19] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/10/2018] [Accepted: 01/13/2019] [Indexed: 12/11/2022]
Abstract
Sampling the blood compartment by an invasive procedure such as phlebotomy is the most common approach used for diagnostic purposes. However, phlebotomy has several drawbacks including pain, vasovagal reactions, and anxiety. Therefore, alternative approaches should be tested to minimize patient's discomfort. Saliva is a reasonable compartment; when obtained, it generates little or no anxiety. We setup a multiplexed serology assay for detection of Toxoplasma gondii IgG and IgM, rubella IgG, and CMV IgG, in serum, whole blood, and saliva using novel plasmonic gold (pGOLD) chips. pGOLD test results in serum, whole blood, and saliva were compared with commercial kits test results in serum. One hundred twenty serum/saliva sets (Lyon) and 28 serum/whole blood/saliva sets (Nice) from France were tested. In serum and whole blood, sensitivity and specificity of multiplex T. gondii, CMV, and rubella IgG were 100% in pGOLD when compared to commercial test results in serum. In saliva, sensitivity and specificity for T. gondii and rubella IgG were 100%, and for CMV IgG, sensitivity and specificity were 92.9% and 100%, respectively, when compared to commercial test results in serum. We were also able to detect T. gondii IgM in saliva with sensitivity and specificity of 100% and 95.4%, respectively, when compared to serum test results. Serological testing by multiplex pGOLD assay for T. gondii, rubella, and CMV in saliva is reliable and likely to be more acceptable for systematic screening of pregnant women, newborn, and immunocompromised patients.
Collapse
Affiliation(s)
- Xiaoyang Li
- Department of Chemistry, Stanford University, William Keck Science Building rm 125, Stanford, CA, 94305-5080, USA
| | - Christelle Pomares
- Service de Parasitologie Mycologie, Centre Hospitalier Universitaire de Nice, INSERM, U1065, Centre Méditerranéen de Médecine Moléculaire, Faculté de Médecine, Virulence microbienne et signalisation inflammatoire - Université de la Côte d'Azur, CS 23079, Nice, cedex 3, France.
| | - François Peyron
- Institut de Parasitologie et de Mycologie Médicale, Hôpital de la Croix Rousse, Lyon, France
| | - Cynthia J Press
- Palo Alto Medical Foundation Toxoplasma Serology Laboratory, Palo Alto, CA, USA
| | - Raymund Ramirez
- Palo Alto Medical Foundation Toxoplasma Serology Laboratory, Palo Alto, CA, USA
| | - Gonfrier Geraldine
- Service de Virologie, Centre Hospitalier Universitaire de Nice, Nice, France
| | - Isabelle Cannavo
- Service de Virologie, Centre Hospitalier Universitaire de Nice, Nice, France
| | - Emmanuelle Chapey
- Emerging Pathogens Laboratory - Fondation Mérieux, Centre, International de Recherche en Infectiologie (CIRI) Inserm U1111, CNRS UMR5308, ENS de Lyon, UCBL1, Lyon, France
| | - Pauline Levigne
- Institut de Parasitologie et de Mycologie Médicale, Hôpital de la Croix Rousse, Lyon, France
| | - Martine Wallon
- Institut de Parasitologie et de Mycologie Médicale, Hôpital de la Croix Rousse, Lyon, France
| | - Jose G Montoya
- Palo Alto Medical Foundation Toxoplasma Serology Laboratory, Palo Alto, CA, USA.
- Division of Infectious Diseases, Department of Medicine, Stanford University, 300 Pasteur Dr, MC 5107, Stanford, CA, 94305, USA.
| | - Hongjie Dai
- Department of Chemistry, Stanford University, William Keck Science Building rm 125, Stanford, CA, 94305-5080, USA.
| |
Collapse
|
21
|
Holder JP, Izumi N, Beach M, Ayers MJ, Bell P, Schneider M, Bradley DK, Kohut T, Ehrlich R, Cohen M, Ramirez R, Thorn D. On the system stability and calibration of the image plate/scanner system for plasma diagnosis at the National Ignition Facility. Rev Sci Instrum 2018; 89:10F123. [PMID: 30399981 DOI: 10.1063/1.5039363] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/07/2018] [Accepted: 07/27/2018] [Indexed: 06/08/2023]
Abstract
At the National Ignition Facility (NIF), storage phosphor image plates (IP) are used extensively for recording x-rays, charged particles, and neutrons. For x-ray imaging and spectroscopy, absolute and relative calibrations are important for extracting plasma information from the diagnostics. We use Fuji MS, SR, and TR image plates that have been cut to fit custom diagnostic envelopes. The image plates are scanned on a General Electric FLA 7000 IP flying spot scanner. Calibrations for sensitivity, spatial scale, and temperature dependent fade are applied. During a set of recent calibrations, we noticed large shifts in the absolute calibration of the image plate system. The possible source of these shifts is discussed. We discuss scanner stability and a method for calibration. We discuss the fade and temperature effects of the image plates and how this correction is applied within the NIF environment. We also compare our NIF GE FLA 7000 IP scanner with a new General Electric Amersham Typhoon IP scanner.
Collapse
Affiliation(s)
- J P Holder
- Lawrence Livermore National Laboratory, Livermore, California 94550, USA
| | - N Izumi
- Lawrence Livermore National Laboratory, Livermore, California 94550, USA
| | - M Beach
- Lawrence Livermore National Laboratory, Livermore, California 94550, USA
| | - M J Ayers
- Lawrence Livermore National Laboratory, Livermore, California 94550, USA
| | - P Bell
- Lawrence Livermore National Laboratory, Livermore, California 94550, USA
| | - M Schneider
- Lawrence Livermore National Laboratory, Livermore, California 94550, USA
| | - D K Bradley
- Lawrence Livermore National Laboratory, Livermore, California 94550, USA
| | - T Kohut
- Lawrence Livermore National Laboratory, Livermore, California 94550, USA
| | - R Ehrlich
- Lawrence Livermore National Laboratory, Livermore, California 94550, USA
| | - M Cohen
- Lawrence Livermore National Laboratory, Livermore, California 94550, USA
| | - R Ramirez
- Lawrence Livermore National Laboratory, Livermore, California 94550, USA
| | - D Thorn
- Lawrence Livermore National Laboratory, Livermore, California 94550, USA
| |
Collapse
|
22
|
Hidalgo M, Epelbaum R, Wolpin B, Stemmer S, Geva R, Golan T, Borazanci E, Borad M, Pedersen K, Park J, Ramirez R, Peled A, Lustig T, Bohana Kashtan O, Rosenfeld O, Sorani E, Schlienger K, Vainstein Haras A, Von Hoff D. A phase IIa trial to assess the safety and efficacy of BL-8040 and pembrolizumab in patients with metastatic pancreatic adenocarcinoma (PDAC). Ann Oncol 2018. [DOI: 10.1093/annonc/mdy288.006] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
23
|
Segelov E, Bergsland E, Card C, Hope T, Kunz P, Laidley D, Lawrence B, Leyden S, Michael M, Modahl L, Myrehaug S, Padda S, Pommier R, Ramirez R, Soulen M, Strosberg J, Thawer A, Wei B, Singh S. The commonwealth neuroendocrine tumour collaboration (CommNETs) and North American neuroendocrine tumor society (NANETS) endorsement and update of European neuroendocrine tumor society (ENETS) best practice consensus for lung neuroendocrine tumors (LNET). Ann Oncol 2018. [DOI: 10.1093/annonc/mdy293.015] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
24
|
Chinnock B, Hendey G, Woolard R, Crawford S, Mainis L, Vo D, Wells R, Ramirez R, Bengiamin D. 148 Sensitivity of a Bedside Reagent Strip for the Detection of Spontaneous Bacterial Peritonitis in Emergency Patients With Ascites. Ann Emerg Med 2018. [DOI: 10.1016/j.annemergmed.2018.08.153] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
25
|
Ramirez R, Voros B, Page P, Boudreaux J, Thiagarajan R, Woltering E. P2.12-07 Utility of Stereotactic Body Radiotherapy in Pulmonary Carcinoid Tumors. J Thorac Oncol 2018. [DOI: 10.1016/j.jtho.2018.08.1383] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
26
|
Broomfield A, Zuberi K, Mercer J, Moss G, Finnegan N, Hensman P, Walker R, Bukhari S, Wright NB, Stewart F, Jones SA, Ramirez R. Outcomes from 18 years of cervical spine surgery in MPS IVA: a single centre's experience. Childs Nerv Syst 2018; 34:1705-1716. [PMID: 29946810 DOI: 10.1007/s00381-018-3823-9] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/11/2017] [Accepted: 05/04/2018] [Indexed: 01/26/2023]
Abstract
PURPOSE This study examines the long-term outcomes of paediatric Morquio (MPS IVA) patients undergoing cervical spine surgery and evaluates the factors that impacting this. METHODS A retrospective review was performed on all MPS IVA patients undergoing cervical spine surgery, since the introduction of standardised neuroradiological screening. The impact of preoperative neurological status, growth, genotype and radiological status on outcome is assessed, whilst long-term surgical, radiological and neurological outcomes are documented. RESULTS Twenty-six of the eighty-two MPS IVA patients (31%) reviewed underwent cervical spine surgery at a median age of 6.1 years (range, 1.45 to 15.24). Preoperatively, cord signal change was seen in 11 patients with 5 being myelopathic; however, 6 clinically manifesting patients had no overt cord signal change. Postoperatively, none of the 14 preoperatively clinically asymptomatic patients followed long term progressed neurologically during a median follow-up of 77.5 months (range = 18-161). Of the ten preoperatively clinically symptomatic patients who were followed up for the same duration, seven continued to deteriorate, two initially improved and one remained stable. Radiological follow-up performed for a median duration of 7 years (range = 0.5-16) has shown a degree of stenosis at the level immediately caudal to the termination of the graft in 76% of patients, though only one has become clinically symptomatic and required revision. CONCLUSIONS Once clinically elicitable neurological signs become evident in patients with MPS IVA, they tend to progress despite surgical intervention. Referring clinicians should also not be falsely reassured by the lack of T2 spinal cord signal change but should consider surgical intervention in the face of new clinical symptomology or radiological signs of progressive canal stenosis or instability.
Collapse
Affiliation(s)
- A Broomfield
- Willink Biochemical Genetics Unit, Manchester Centre for Genomic Medicine, St Mary's Hospital, Central Manchester Foundation Trust, Manchester, M13 9WL, UK.
| | - K Zuberi
- Faculty of Biology, Medicine and Health, The University of Manchester, Oxford Rd, Manchester, M13 9PL, UK
| | - J Mercer
- Willink Biochemical Genetics Unit, Manchester Centre for Genomic Medicine, St Mary's Hospital, Central Manchester Foundation Trust, Manchester, M13 9WL, UK
| | - G Moss
- Willink Biochemical Genetics Unit, Manchester Centre for Genomic Medicine, St Mary's Hospital, Central Manchester Foundation Trust, Manchester, M13 9WL, UK
| | - N Finnegan
- Willink Biochemical Genetics Unit, Manchester Centre for Genomic Medicine, St Mary's Hospital, Central Manchester Foundation Trust, Manchester, M13 9WL, UK
| | - P Hensman
- Department of Physiotherapy, Royal Manchester Children's Hospital, Central Manchester Foundation Trust, Manchester, M13 9WL, UK
| | - R Walker
- Department of Paediatric Anaesthetics, Royal Manchester Children's Hospital, Central Manchester Foundation Trust, Manchester, M13 9WL, UK
| | - S Bukhari
- Department of Paediatric Neurosurgery, Royal Manchester Children's Hospital, Central Manchester Foundation Trust, Manchester, M13 9WL, UK
| | - N B Wright
- Department of Paediatric Radiology, Royal Manchester Children's Hospital, Central Manchester Foundation Trust, Manchester, M13 9WL, UK
| | - F Stewart
- N.I Regional Genetics Service, Level A, Belfast City Hospital, Lisburn Rd, Belfast, BT9 7AB, UK
| | - S A Jones
- Willink Biochemical Genetics Unit, Manchester Centre for Genomic Medicine, St Mary's Hospital, Central Manchester Foundation Trust, Manchester, M13 9WL, UK
| | - R Ramirez
- Department of Paediatric Neurosurgery, Royal Manchester Children's Hospital, Central Manchester Foundation Trust, Manchester, M13 9WL, UK
| |
Collapse
|
27
|
Lykins J, Li X, Levigne P, Zhou Y, El Bissati K, Clouser F, Wallon M, Morel F, Leahy K, El Mansouri B, Siddiqui M, Leong N, Michalowski M, Irwin E, Goodall P, Ismail M, Christmas M, Adlaoui EB, Rhajaoui M, Barkat A, Cong H, Begeman IJ, Lai BS, Contopoulos-Ioannidis DG, Montoya JG, Maldonado Y, Ramirez R, Press C, Peyron F, McLeod R. Rapid, inexpensive, fingerstick, whole-blood, sensitive, specific, point-of-care test for anti-Toxoplasma antibodies. PLoS Negl Trop Dis 2018; 12:e0006536. [PMID: 30114251 PMCID: PMC6095485 DOI: 10.1371/journal.pntd.0006536] [Citation(s) in RCA: 20] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/02/2022] Open
Affiliation(s)
- Joseph Lykins
- Pritzker School of Medicine, University of Chicago, Chicago, Illinois, United States of America
| | - Xuan Li
- Rush Medical College, Rush University, Chicago, Illinois, United States of America
| | - Pauline Levigne
- Institut de Parasitologie et de Mycologie Médicale Hôpital de la Croix Rousse, Lyon, France
| | - Ying Zhou
- Department of Ophthalmology and Visual Sciences, University of Chicago, Chicago, Illinois, United States of America
| | - Kamal El Bissati
- Department of Ophthalmology and Visual Sciences, University of Chicago, Chicago, Illinois, United States of America
| | - Fatima Clouser
- Department of Ophthalmology and Visual Sciences, University of Chicago, Chicago, Illinois, United States of America
| | - Martine Wallon
- Institut de Parasitologie et de Mycologie Médicale Hôpital de la Croix Rousse, Lyon, France
| | - Florence Morel
- Institut de Parasitologie et de Mycologie Médicale Hôpital de la Croix Rousse, Lyon, France
| | - Karen Leahy
- Department of Obstetrics and Gynecology, University of Chicago, Chicago, Illinois, United States of America
| | | | - Maryam Siddiqui
- Department of Obstetrics and Gynecology, University of Chicago, Chicago, Illinois, United States of America
| | - Nicole Leong
- Department of Obstetrics and Gynecology, University of Chicago, Chicago, Illinois, United States of America
| | - Morgan Michalowski
- Department of Obstetrics and Gynecology, University of Chicago, Chicago, Illinois, United States of America
| | - Erin Irwin
- Department of Obstetrics and Gynecology, University of Chicago, Chicago, Illinois, United States of America
| | - Perpetua Goodall
- Department of Obstetrics and Gynecology, University of Chicago, Chicago, Illinois, United States of America
| | - Mahmoud Ismail
- Department of Obstetrics and Gynecology, University of Chicago, Chicago, Illinois, United States of America
| | - Monica Christmas
- Department of Obstetrics and Gynecology, University of Chicago, Chicago, Illinois, United States of America
| | | | | | - Amina Barkat
- Équipe de recherche en santé et nutrition du couple mère enfant, Faculté de Médecine et de Pharmacie de Rabat, Université Mohammed V, Rabat, Morocco
| | - Hua Cong
- Department of Ophthalmology and Visual Sciences, University of Chicago, Chicago, Illinois, United States of America
| | - Ian J. Begeman
- Department of Ophthalmology and Visual Sciences, University of Chicago, Chicago, Illinois, United States of America
| | - Bo Shiun Lai
- Department of Ophthalmology and Visual Sciences, University of Chicago, Chicago, Illinois, United States of America
| | - Despina G. Contopoulos-Ioannidis
- Department of Pediatrics, Division of Infectious Diseases, Stanford University School of Medicine, Stanford, California, United States of America
| | - Jose G. Montoya
- Palo Alto Medical Foundation Toxoplasma Serology Laboratory, Palo Alto, California, United States of America
- Department of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, California, United States of America
| | - Yvonne Maldonado
- Department of Pediatrics, Division of Infectious Diseases, Stanford University School of Medicine, Stanford, California, United States of America
- Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California, United States of America
| | - Raymund Ramirez
- Palo Alto Medical Foundation Toxoplasma Serology Laboratory, Palo Alto, California, United States of America
| | - Cindy Press
- Palo Alto Medical Foundation Toxoplasma Serology Laboratory, Palo Alto, California, United States of America
| | - Francois Peyron
- Institut de Parasitologie et de Mycologie Médicale Hôpital de la Croix Rousse, Lyon, France
| | - Rima McLeod
- Pritzker School of Medicine, University of Chicago, Chicago, Illinois, United States of America
- Section of Infectious Diseases, Department of Pediatrics, Institute of Genomics, Genetics, and Systems Biology, Global Health Center, Toxoplasmosis Center, CHeSS, The College, University of Chicago, Chicago, Illinois, United States of America
- * E-mail:
| |
Collapse
|
28
|
Gnatiuc L, Alegre-Diaz J, Wade R, Ramirez R, Herrington WG, Solano M, Clarke R, Lewington SL, Collins R, Peto R, Tapia-Conyer R, Emberson J, Kuri-Morales P. P6282Adiposity and vascular-metabolic mortality among 150,000 Mexican adults followed for 15 years. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy566.p6282] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
- L Gnatiuc
- University of Oxford, CTSU, Oxford, United Kingdom
| | - J Alegre-Diaz
- National Autonomous University of Mexico, School of Medicine, Mexico City, Mexico
| | - R Wade
- University of Oxford, MRC Population Health Research Unit; Nuffield Department of Population Health, Oxford, United Kingdom
| | - R Ramirez
- National Autonomous University of Mexico, School of Medicine, Mexico City, Mexico
| | | | - M Solano
- National Autonomous University of Mexico, School of Medicine, Mexico City, Mexico
| | - R Clarke
- University of Oxford, CTSU, Oxford, United Kingdom
| | - S L Lewington
- University of Oxford, MRC Population Health Research Unit; Nuffield Department of Population Health, Oxford, United Kingdom
| | - R Collins
- University of Oxford, CTSU, Oxford, United Kingdom
| | - R Peto
- University of Oxford, CTSU, Oxford, United Kingdom
| | - R Tapia-Conyer
- National Autonomous University of Mexico, School of Medicine, Mexico City, Mexico
| | - J Emberson
- University of Oxford, MRC Population Health Research Unit; Nuffield Department of Population Health, Oxford, United Kingdom
| | - P Kuri-Morales
- National Autonomous University of Mexico, School of Medicine, Mexico City, Mexico
| |
Collapse
|
29
|
Alegre-Diaz J, Gnatiuc L, Wade R, Ramirez R, Herrington W, Lewington S, Lopez Cervantes M, Solano M, Peto R, Collins R, Tapia-Conyer R, Kuri-Morales P, Emberson J. P6257Blood pressure and death from vascular and metabolic diseases in Mexico City: 12-year follow-up of 150,000 adults. Eur Heart J 2017. [DOI: 10.1093/eurheartj/ehx493.p6257] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
- J. Alegre-Diaz
- National Autonomous University of Mexico, School of Medicine, Mexico City, Mexico
| | - L. Gnatiuc
- University of Oxford, CTSU, Nuffield Department of Population Health,, Oxford, United Kingdom
| | - R. Wade
- University of Oxford, MRC Population Health Research Unit; Nuffield Department of Population Health, Oxford, United Kingdom
| | - R. Ramirez
- National Autonomous University of Mexico, School of Medicine, Mexico City, Mexico
| | - W.G. Herrington
- University of Oxford, CTSU, Nuffield Department of Population Health,, Oxford, United Kingdom
| | - S.L. Lewington
- University of Oxford, MRC Population Health Research Unit; Nuffield Department of Population Health, Oxford, United Kingdom
| | - M. Lopez Cervantes
- National Autonomous University of Mexico, School of Medicine, Mexico City, Mexico
| | - M. Solano
- National Autonomous University of Mexico, School of Medicine, Mexico City, Mexico
| | - R. Peto
- University of Oxford, CTSU, Nuffield Department of Population Health,, Oxford, United Kingdom
| | - R. Collins
- University of Oxford, CTSU, Nuffield Department of Population Health,, Oxford, United Kingdom
| | - R. Tapia-Conyer
- National Autonomous University of Mexico, School of Medicine, Mexico City, Mexico
| | - P. Kuri-Morales
- National Autonomous University of Mexico, School of Medicine, Mexico City, Mexico
| | - J.R. Emberson
- University of Oxford, MRC Population Health Research Unit; Nuffield Department of Population Health, Oxford, United Kingdom
| | | |
Collapse
|
30
|
Begeman IJ, Lykins J, Zhou Y, Lai BS, Levigne P, El Bissati K, Boyer K, Withers S, Clouser F, Noble AG, Rabiah P, Swisher CN, Heydemann PT, Contopoulos-Ioannidis DG, Montoya JG, Maldonado Y, Ramirez R, Press C, Stillwaggon E, Peyron F, McLeod R. Point-of-care testing for Toxoplasma gondii IgG/IgM using Toxoplasma ICT IgG-IgM test with sera from the United States and implications for developing countries. PLoS Negl Trop Dis 2017. [PMID: 28650970 PMCID: PMC5501679 DOI: 10.1371/journal.pntd.0005670] [Citation(s) in RCA: 30] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023] Open
Abstract
Background Congenital toxoplasmosis is a serious but preventable and treatable disease. Gestational screening facilitates early detection and treatment of primary acquisition. Thus, fetal infection can be promptly diagnosed and treated and outcomes can be improved. Methods We tested 180 sera with the Toxoplasma ICT IgG-IgM point-of-care (POC) test. Sera were from 116 chronically infected persons (48 serotype II; 14 serotype I-III; 25 serotype I-IIIa; 28 serotype Atypical, haplogroup 12; 1 not typed). These represent strains of parasites infecting mothers of congenitally infected children in the U.S. 51 seronegative samples and 13 samples from recently infected persons known to be IgG/IgM positive within the prior 2.7 months also were tested. Interpretation was confirmed by two blinded observers. A comparison of costs for POC vs. commercial laboratory testing methods was performed. Results We found that this new Toxoplasma ICT IgG-IgM POC test was highly sensitive (100%) and specific (100%) for distinguishing IgG/IgM-positive from negative sera. Use of such reliable POC tests can be cost-saving and benefit patients. Conclusions Our work demonstrates that the Toxoplasma ICT IgG-IgM test can function reliably as a point-of-care test to diagnose Toxoplasma gondii infection in the U.S. This provides an opportunity to improve maternal-fetal care by using approaches, diagnostic tools, and medicines already available. This infection has serious, lifelong consequences for infected persons and their families. From the present study, it appears a simple, low-cost POC test is now available to help prevent morbidity/disability, decrease cost, and make gestational screening feasible. It also offers new options for improved prenatal care in low- and middle-income countries. Toxoplasmosis, a disease caused by the parasite Toxoplasma gondii, presents a major health burden in both the developed and developing world. Untreated congenital toxoplasmosis causes damage to the eye and brain, but early detection and treatment reduce transmission and disease. Fetal infection can be promptly diagnosed and treated and outcomes can be improved. Gestational screening for toxoplasmosis has international precedent. In this paper, we demonstrated that the new Toxoplasma ICT IgG-IgM test had 100% sensitivity and specificity in detecting Toxoplasma infection (N = 180 U.S. sera from uninfected persons and those with varying parasite serotypes). The use of an inexpensive, easy-to-use point-of-care test facilitates screening of pregnant women for T. gondii infection. In turn, this facilitates prompt treatment for the infection and thereby reduces the health burden caused by this disease. This provides an opportunity to improve maternal-fetal care by using approaches, diagnostic tools, and medicines already available.
Collapse
Affiliation(s)
- Ian J. Begeman
- Department of Ophthalmology and Visual Science, The University of Chicago, Chicago, Illinois, United States of America
| | - Joseph Lykins
- Pritzker School of Medicine, The University of Chicago, Chicago, Illinois, United States of America
| | - Ying Zhou
- Department of Ophthalmology and Visual Science, The University of Chicago, Chicago, Illinois, United States of America
| | - Bo Shiun Lai
- Department of Ophthalmology and Visual Science, The University of Chicago, Chicago, Illinois, United States of America
| | - Pauline Levigne
- Institut de Parasitologie et de Mycologie Médicale Hôpital de la Croix Rousse, Lyon, France
| | - Kamal El Bissati
- Department of Ophthalmology and Visual Science, The University of Chicago, Chicago, Illinois, United States of America
| | - Kenneth Boyer
- Department of Ophthalmology and Visual Science, The University of Chicago, Chicago, Illinois, United States of America
- Rush University and Medical Center, Chicago, Illinois, United States of America
| | - Shawn Withers
- Department of Ophthalmology and Visual Science, The University of Chicago, Chicago, Illinois, United States of America
| | - Fatima Clouser
- Department of Ophthalmology and Visual Science, The University of Chicago, Chicago, Illinois, United States of America
| | - A. Gwendolyn Noble
- Department of Ophthalmology and Visual Science, The University of Chicago, Chicago, Illinois, United States of America
- Lurie Children’s Hospital and Northwestern University, Chicago, Illinois, United States of America
| | - Peter Rabiah
- Department of Ophthalmology and Visual Science, The University of Chicago, Chicago, Illinois, United States of America
- Northshore Hospital, Evanston, Illinois, United States of America
| | - Charles N. Swisher
- Department of Ophthalmology and Visual Science, The University of Chicago, Chicago, Illinois, United States of America
- Lurie Children’s Hospital and Northwestern University, Chicago, Illinois, United States of America
| | - Peter T. Heydemann
- Department of Ophthalmology and Visual Science, The University of Chicago, Chicago, Illinois, United States of America
- Rush University and Medical Center, Chicago, Illinois, United States of America
| | - Despina G. Contopoulos-Ioannidis
- Department of Pediatrics, Division of Infectious Diseases, Stanford University School of Medicine, Stanford, California, United States of America
| | - Jose G. Montoya
- Palo Alto Medical Foundation Toxoplasma Serology Laboratory, Palo Alto, California, United States of America
- Department of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, California, United States of America
| | - Yvonne Maldonado
- Department of Pediatrics, Division of Infectious Diseases, Stanford University School of Medicine, Stanford, California, United States of America
- Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California, United States of America
| | - Raymund Ramirez
- Palo Alto Medical Foundation Toxoplasma Serology Laboratory, Palo Alto, California, United States of America
| | - Cindy Press
- Palo Alto Medical Foundation Toxoplasma Serology Laboratory, Palo Alto, California, United States of America
| | | | - François Peyron
- Institut de Parasitologie et de Mycologie Médicale Hôpital de la Croix Rousse, Lyon, France
| | - Rima McLeod
- Department of Ophthalmology and Visual Science, The University of Chicago, Chicago, Illinois, United States of America
- Department of Pediatrics (Infectious Diseases), Institute of Genomics, Genetics, and Systems Biology, Global Health Center, Toxoplasmosis Center, the Center for Health and the Social Sciences, CHeSS, the College, The University of Chicago, Chicago Medicine, Chicago, Illinois, United States of America
- * E-mail:
| |
Collapse
|
31
|
Pomares C, Holmes TH, Estran R, Press CJ, Ramirez R, Talucod J, Maecker H, Rosenberg-Hasson Y, Montoya JG. Cytokine profiles in patients with toxoplasmic lymphadenitis in the setting of pregnancy. Cytokine 2016; 90:14-20. [PMID: 27744174 DOI: 10.1016/j.cyto.2016.09.021] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/08/2016] [Revised: 09/23/2016] [Accepted: 09/26/2016] [Indexed: 01/27/2023]
Abstract
INTRODUCTION Majority of Toxoplasma gondii infections are benign and asymptomatic; however, some patients experience toxoplasmic lymphadenitis (TL). Factors associated as to whether infection will be symptomatic or not are unknown. METHODS Dye test titers of patients with acute toxoplasmosis (pregnant and not pregnant) with TL (TL+) were compared with those in patients with asymptomatic acute infection (TL-). Additionally, mean levels of 62 serum cytokines were compared between TL+ and TL- pregnant women and between TL+ pregnant and non-pregnant women. RESULTS During acute infection, mean dye test titer was higher in TL+ than in TL- patients (p=0.021). In addition, out of 62 cytokines, CXCL9andCXCL10 levels were higher (p<0.05) and resistin mean levels were lower (p<0.05) in pregnant women with TL+ compared to TL-. Among patients with TL+, levels of VCAM1andCCL2 were lower (p<0.05) in pregnant women than in non-pregnant women. CONCLUSION Here we report differences in dye test titers in patients with acute infection. Cytokine responses vary according to the presence of TL+ and to the pregnancy status. Factors underlying these differences are presently unknown and require further studies to define individual and combined roles of cytokines in TL+.
Collapse
Affiliation(s)
- Christelle Pomares
- Palo Alto Medical Foundation Toxoplasma Serology Laboratory, Palo Alto, CA, USA; Division of Infectious Diseases, Stanford University, Stanford, CA 94305, USA; INSERM, U1065, Centre Méditerranéen de Médecine Moléculaire, C3M, Toxines Microbiennes dans la Relation Hôte Pathogènes - Université de Nice Sophia Antipolis d, Faculté de Médecine, 06204 Nice Cedex 3, France; Parasitologie-Mycologie, Centre Hospitalier Universitaire l'Archet e, CS 23079, 06202 Nice Cedex 3, France.
| | - Tyson H Holmes
- Stanford University Human Immune Monitoring Centre, Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA 94305, USA
| | | | - Cynthia J Press
- Palo Alto Medical Foundation Toxoplasma Serology Laboratory, Palo Alto, CA, USA
| | - Raymund Ramirez
- Palo Alto Medical Foundation Toxoplasma Serology Laboratory, Palo Alto, CA, USA
| | - Jeanne Talucod
- Palo Alto Medical Foundation Toxoplasma Serology Laboratory, Palo Alto, CA, USA
| | - Holden Maecker
- Department of Immunology, Fairchild Science Building, D033, 299 Campus Drive, Stanford University School of Medicine, Stanford, CA 94305-5124, USA
| | - Yael Rosenberg-Hasson
- Department of Immunology, Fairchild Science Building, D033, 299 Campus Drive, Stanford University School of Medicine, Stanford, CA 94305-5124, USA
| | - Jose G Montoya
- Palo Alto Medical Foundation Toxoplasma Serology Laboratory, Palo Alto, CA, USA; Division of Infectious Diseases, Stanford University, Stanford, CA 94305, USA
| |
Collapse
|
32
|
Stalcup P, Croft B, Ramirez R, Darracq M. 204 Haloperidol Undermining Gastroparesis Symptoms in the Emergency Department. Ann Emerg Med 2016. [DOI: 10.1016/j.annemergmed.2016.08.218] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
33
|
Gellert GA, Hill V, Bruner K, Maciaz G, Saucedo L, Catzoela L, Ramirez R, Jacobs WJ, Nguyen P, Patel L, Webster SL. Successful Implementation of Clinical Information Technology: Seven Key Lessons from CPOE. Appl Clin Inform 2015; 6:698-715. [PMID: 26767065 DOI: 10.4338/aci-2015-06-soa-0067] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/11/2015] [Accepted: 10/08/2015] [Indexed: 11/23/2022] Open
Abstract
OBJECTIVES To identify and describe the most critical strategic and operational contributors to the successful implementation of clinical information technologies, as deployed within a moderate sized system of U.S. community hospitals. BACKGROUND AND SETTING CHRISTUS Health is a multi-state system comprised of more than 350 services and 60 hospitals with over 9 000 physicians. The Santa Rosa region of CHRISTUS Health, located in greater San Antonio, Texas is comprised of three adult community hospital facilities and one Children's hospital each with bed capacities of 142-180. Computerized Patient Order Entry (CPOE) was first implemented in 2012 within a complex market environment. The Santa Rosa region has 2 417 credentialed physicians and 263 mid-level allied health professionals. METHODS This report focuses on the seven most valuable strategies deployed by the Health Informatics team in a large four hospital CHRISTUS region to achieve strong CPOE adoption and critical success lessons learned. The findings are placed within the context of the literature describing best practices in health information technology implementation. RESULTS While the elements described involved discrete de novo process generation to support implementation and operations, collectively they represent the creation of a new customer-centric service culture in our Health Informatics team, which has served as a foundation for ensuring strong clinical information technology adoption beyond CPOE. CONCLUSION The seven success factors described are not limited in their value to and impact on CPOE adoption, but generalize to - and can advance success in - varied other clinical information technology implementations across diverse hospitals. A number of these factors are supported by reports in the literature of other institutions' successful implementations of CPOE and other clinical information technologies, and while not prescriptive to other settings, may be adapted to yield value elsewhere.
Collapse
Affiliation(s)
- G A Gellert
- CHRISTUS Health, Health Informatics , San Antonio, TX, United States
| | - V Hill
- Baylor College of Medicine, Pediatrics , San Antonio, TX, United States
| | - K Bruner
- CHRISTUS Health, Health Informatics , San Antonio, TX, United States
| | - G Maciaz
- CHRISTUS Health, Health Informatics , San Antonio, TX, United States
| | - L Saucedo
- CHRISTUS Health, Health Informatics , San Antonio, TX, United States
| | - L Catzoela
- CHRISTUS Health, Health Informatics , San Antonio, TX, United States
| | - R Ramirez
- CHRISTUS Health, Health Informatics , San Antonio, TX, United States
| | - W J Jacobs
- CHRISTUS Health, Health Informatics , San Antonio, TX, United States
| | - P Nguyen
- CHRISTUS Santa Rosa Westover Hills Hospital , San Antonio, TX, United States
| | - L Patel
- CHRISTUS Santa Rosa Medical Center , San Antonio, TX, United States
| | - S L Webster
- CHRISTUS Health, Health Informatics , San Antonio, TX, United States
| |
Collapse
|
34
|
Muñoz M, Moreno O, Yuste E, Poyatos ME, Ramirez R, Narbona S. Acynetobacter baumanii extremely resistant outbreak control in ICU: a multidisciplinary approach. Intensive Care Med Exp 2015. [PMCID: PMC4798271 DOI: 10.1186/2197-425x-3-s1-a132] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
35
|
Contopoulos-Ioannidis D, Wheeler KM, Ramirez R, Press C, Mui E, Zhou Y, Van Tubbergen C, Prasad S, Maldonado Y, Withers S, Boyer KM, Noble AG, Rabiah P, Swisher CN, Heydemann P, Wroblewski K, Karrison T, Grigg ME, Montoya JG, McLeod R. Clustering of Toxoplasma gondii Infections Within Families of Congenitally Infected Infants. Clin Infect Dis 2015; 61:1815-24. [PMID: 26405150 DOI: 10.1093/cid/civ721] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/31/2015] [Accepted: 08/07/2015] [Indexed: 11/13/2022] Open
Abstract
BACKGROUND Family clusters and epidemics of toxoplasmosis in North, Central, and South America led us to determine whether fathers of congenitally infected infants in the National Collaborative Chicago-Based Congenital Toxoplasmosis Study (NCCCTS) have a high incidence of Toxoplasma gondii infection. METHODS We analyzed serum samples collected from NCCCTS families between 1981 and 2013. Paternal serum samples were tested for T. gondii antibodies with immunoglobulin (Ig) G dye test and IgM enzyme-linked immunosorbent assay. Additional testing of paternal serum samples was performed with differential-agglutination and IgG avidity tests when T. gondii IgG and IgM results were positive and serum samples were collected by the 1-year visit of the congenitally infected child. Prevalence of paternal seropositivity and incidence of recent infection were calculated. We analyzed whether certain demographics, maternal parasite serotype, risk factors, or maternal/infant clinical manifestations were associated with paternal T. gondii infection status. RESULTS Serologic testing revealed a high prevalence (29 of 81; 36%) of T. gondii infection in fathers, relative to the average seropositivity rate of 9.8% for boys and men aged 12-49 years in the United States between 1994 and 2004 (P < .001). Moreover, there was a higher-than-expected incidence of recent infections among fathers with serum samples collected by the 1-year visit of their child (6 of 45; 13%; P < .001). No demographic patterns or clinical manifestations in mothers or infants were associated with paternal infections, except for sandbox exposure. CONCLUSIONS The high prevalence of chronic and incidence of recent T. gondii infections in fathers of congenitally infected children indicates that T. gondii infections cluster within families in North America. When a recently infected person is identified, family clustering and community risk factors should be investigated for appropriate clinical management.
Collapse
Affiliation(s)
- Despina Contopoulos-Ioannidis
- Department of Pediatrics, Division of Infectious Diseases Palo Alto Medical Foundation Toxoplasma Serology Laboratory, California
| | - Kelsey M Wheeler
- Departments of Ophthalmology and Visual Sciences and Pediatric Infectious Diseases, Toxoplasmosis Center, Department of Public Health Sciences, University of Chicago
| | - Raymund Ramirez
- Palo Alto Medical Foundation Toxoplasma Serology Laboratory, California
| | - Cindy Press
- Palo Alto Medical Foundation Toxoplasma Serology Laboratory, California
| | - Ernest Mui
- Departments of Ophthalmology and Visual Sciences and Pediatric Infectious Diseases, Toxoplasmosis Center, Department of Public Health Sciences, University of Chicago
| | - Ying Zhou
- Departments of Ophthalmology and Visual Sciences and Pediatric Infectious Diseases, Toxoplasmosis Center, Department of Public Health Sciences, University of Chicago
| | - Christine Van Tubbergen
- Departments of Ophthalmology and Visual Sciences and Pediatric Infectious Diseases, Toxoplasmosis Center, Department of Public Health Sciences, University of Chicago
| | - Sheela Prasad
- Departments of Ophthalmology and Visual Sciences and Pediatric Infectious Diseases, Toxoplasmosis Center, Department of Public Health Sciences, University of Chicago
| | | | - Shawn Withers
- Departments of Ophthalmology and Visual Sciences and Pediatric Infectious Diseases, Toxoplasmosis Center, Department of Public Health Sciences, University of Chicago
| | - Kenneth M Boyer
- Departments of Ophthalmology and Visual Sciences and Pediatric Infectious Diseases, Toxoplasmosis Center, Department of Public Health Sciences, University of Chicago Department of Pediatrics, Rush University Medical Center
| | - A Gwendolyn Noble
- Departments of Ophthalmology and Visual Sciences and Pediatric Infectious Diseases, Toxoplasmosis Center, Department of Public Health Sciences, University of Chicago Lurie Children's Hospital, Northwestern Memorial Hospital, Northwestern University, Chicago
| | - Peter Rabiah
- Departments of Ophthalmology and Visual Sciences and Pediatric Infectious Diseases, Toxoplasmosis Center, Department of Public Health Sciences, University of Chicago North Shore University Hospital, Evanston, Illinois
| | - Charles N Swisher
- Departments of Ophthalmology and Visual Sciences and Pediatric Infectious Diseases, Toxoplasmosis Center, Department of Public Health Sciences, University of Chicago Lurie Children's Hospital, Northwestern Memorial Hospital, Northwestern University, Chicago
| | - Peter Heydemann
- Departments of Ophthalmology and Visual Sciences and Pediatric Infectious Diseases, Toxoplasmosis Center, Department of Public Health Sciences, University of Chicago Department of Pediatrics, Rush University Medical Center
| | - Kristen Wroblewski
- Departments of Ophthalmology and Visual Sciences and Pediatric Infectious Diseases, Toxoplasmosis Center, Department of Public Health Sciences, University of Chicago
| | - Theodore Karrison
- Departments of Ophthalmology and Visual Sciences and Pediatric Infectious Diseases, Toxoplasmosis Center, Department of Public Health Sciences, University of Chicago
| | - Michael E Grigg
- Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland
| | - Jose G Montoya
- Department of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine Palo Alto Medical Foundation Toxoplasma Serology Laboratory, California
| | - Rima McLeod
- Departments of Ophthalmology and Visual Sciences and Pediatric Infectious Diseases, Toxoplasmosis Center, Department of Public Health Sciences, University of Chicago
| |
Collapse
|
36
|
Caussade S, Castro-Rodriguez J, Contreras S, Bugueño R, Ramirez R, Padilla O, Einisman H, Holmgren N. Methacholine challenge test by wheezing and oxygen saturation in preschool children with asthma. Allergol Immunopathol (Madr) 2015; 43:174-9. [PMID: 24948183 DOI: 10.1016/j.aller.2014.02.005] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/15/2013] [Revised: 01/17/2014] [Accepted: 02/25/2014] [Indexed: 10/25/2022]
Abstract
UNLABELLED Methacholine challenge test (MCT) performed with spirometry is a commonly used test to evaluate bronchial hyperreactivity (BHR) in children. However, preschoolers do not usually collaborate. OBJECTIVES To assess the usefulness of MCT through clinical evaluation (wheezing auscultation and decreased pulse arterial oxygen saturation [SpO2]) in recurrent wheezing preschoolers with asthma, in comparison to healthy controls. METHODS We performed the MCT (modified Cockroft method) on healthy and on asthmatic preschoolers. The end point was determined by the presence of wheezing in the chest and/or tracheal auscultation (PCw) and/or a decrease in SpO2 of ≥5 from the baseline value (PCSpO2). Maximal methacholine concentration was 8 mg/ml. RESULTS The study population comprised 65 children: 32 healthy and 33 asthmatic children. There were no differences in demographic characteristics between the groups. The median methacholine doses for PCw and for PCSpO2 were significantly lower among asthmatic than healthy children: 0.5 mg/ml (0.25-0.5 mg/ml) vs. 2 mg/ml (1-4 mg/ml), respectively, p<0.001; and 0.25 mg/ml (0.25-0.5 mg/ml) and 2 mg/ml (0.5-4 mg/ml), respectively, p<0.001. The best cut-off point of PCw was observed at a methacholine concentration of 0.5 mg/ml (AUC=0.72 [95% CI=0.66-0.77]), its sensitivity was 91%, specificity 43%, PPV 16% and NPV 98%. For PCSpO2 the best cut-off point was a methacholine concentration of 1 mg/ml (AUC=0.85 [95% CI 0.81-0.89]), with sensitivity of 80%, specificity 74%, PPV 49%, and NPV 92%. There were no adverse reactions. CONCLUSION MCT using clinical parameters such as wheezing auscultation and SpO2 measurement could be a useful and safe test to confirm BHR among preschoolers.
Collapse
|
37
|
Pernas L, Ramirez R, Holmes TH, Montoya JG, Boothroyd JC. Immune profiling of pregnant Toxoplasma-infected US and Colombia patients reveals surprising impacts of infection on peripheral blood cytokines. J Infect Dis 2014; 210:923-31. [PMID: 24664173 DOI: 10.1093/infdis/jiu189] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
In North America (NA) and Europe, the majority of toxoplasmosis cases are benign and generally asymptomatic, whereas in South America (SA) toxoplasmosis is associated with much more severe symptoms in adults and congenitally infected children. The reasons for these differences remain unknown; currently, there is little information from patients in either region on how the immune system responds to infection with Toxoplasma gondii. Here, we report the relative abundance of 51 serum cytokines from acute and chronic toxoplasmosis cohorts of pregnant women from the United States, where approximately one-half of clinical isolates are Type II, and Colombia, where clinical isolates are generally "atypical" or Type I-like strains. Surprisingly, the results showed notably lower levels of 23 cytokines in acutely infected patients from the United States, relative to uninfected US controls. In acutely infected Colombian patients, however, only 8 cytokine levels differed detectably with 4 being lower and 4 higher relative to uninfected controls. Strikingly, there were also differences in the cytokine profiles of the chronically infected patients relative to uninfected controls in the US cohort. Hence, Toxoplasma appears to specifically impact levels of circulating cytokines, and our results may partly explain region-specific differences in the clinical spectrum of toxoplasmosis.
Collapse
Affiliation(s)
- Lena Pernas
- Department of Microbiology and Immunology, Stanford University School of Medicine
| | - Raymund Ramirez
- Palo Alto Medical Foundation Toxoplasmosis Serology Laboratory
| | - Tyson H Holmes
- Stanford Center for Human Sleep Research, Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine
| | - José G Montoya
- Palo Alto Medical Foundation Toxoplasmosis Serology Laboratory Division of Infectious Diseases and Geographic Medicine and Department of Medicine, Stanford University School of Medicine, California
| | - John C Boothroyd
- Department of Microbiology and Immunology, Stanford University School of Medicine
| |
Collapse
|
38
|
Banh K, Ramirez R. Effectiveness of Emergency Medicine Experience in Third-Year Integrated Longitudinal Medical Student Programs. Ann Emerg Med 2013. [DOI: 10.1016/j.annemergmed.2013.06.046] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
39
|
Mateo C, Castell V, Julián R, Alarcon T, Otero A, Ramirez R, Duran E, Gutierrez-Misis A. Prevalence of hypovitaminosis D in a population of 65years and older. Eur Geriatr Med 2013. [DOI: 10.1016/j.eurger.2013.07.494] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
40
|
De Lorenzi A, Olea FD, Hnatiuk A, Valdivieso L, Locatelli P, Ramirez R, Sepulveda D, Laguens R, Crottogini A. Effects of genetically modified adipose stromal cells implantation in rabbits with experimental peripheral vascular disease. Eur Heart J 2013. [DOI: 10.1093/eurheartj/eht309.p3273] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
41
|
Julian R, Ramirez R, Rueda M, Latorre A, Castell V, Melgar A, Martin L, Duran E. AB1418-PC Impact of the physiotherapy unit in an urban primary care health centre. Ann Rheum Dis 2013. [DOI: 10.1136/annrheumdis-2012-eular.1410] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
42
|
Girard OM, Ramirez R, McCarty S, Mattrey RF. Toward absolute quantification of iron oxide nanoparticles as well as cell internalized fraction using multiparametric MRI. Contrast Media Mol Imaging 2012; 7:411-7. [PMID: 22649047 DOI: 10.1002/cmmi.1467] [Citation(s) in RCA: 50] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/11/2023]
Abstract
Iron oxide nanoparticles (IONPs) are widely used as MR contrast agents because of their strong magnetic properties and broad range of applications. The contrast induced by IONPs typically depends on concentration, water accessibility, particle size and heterogeneity of IONP distribution within the microenvironment. Although the latter could be a tool to assess local physiological effects at the molecular level, it renders IONP quantification from relaxation measurements challenging. This study aims to quantify IONP concentration using susceptibility measurements. In addition, further analysis of relaxation data is proposed to extract quantitative information about the IONP spatial distribution. Mesenchymal stem cells were labeled with IONPs and the IONP concentration measured by mass spectroscopy. MR relaxation parameters (T(1), T(2), T(2)*) as well as magnetic susceptibility of cylindrical samples containing serial dilutions of mixtures of free and cell-internalized IONPs were measured and correlated with IONP concentration. Unlike relaxation data, magnetic susceptibility was independent of whether IONPs were free or internalized, making it an excellent candidate for IONP quantification. Using IONP concentration derived from mass spectroscopy and measured relaxation times, free and internalized IONP fractions were accurately calculated. Magnetic susceptibility was shown to be a robust technique to measure IONP concentration in this preliminary study. Novel imaging-based susceptibility mapping techniques could prove to be valuable tools to quantify IONP concentration directly by MRI, for samples of arbitrary shape. Combined with relaxation time mapping techniques, especially T(2) and T(2)*, this could be an efficient way to measure both IONP concentration and the internalized IONP fraction in vivo using MRI, to gain insight into tissue function and molecular imaging paradigms.
Collapse
Affiliation(s)
- O M Girard
- Department of Radiology, University of California San Diego, USA.
| | | | | | | |
Collapse
|
43
|
Kaushal G, Ramirez R, Alambo D, Taupradist W, Choksi K, Sirbu C. Initial characterization of D-cycloserine for future formulation development for anxiety disorders. Drug Discov Ther 2012; 5:253-60. [PMID: 22466372 DOI: 10.5582/ddt.2011.v5.5.253] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
The purpose of this study is to characterize D-cycloserine (DCS) physicochemical properties to facilitate future formulation development of DCS for anxiety disorders. A stability-indicating HPLC assay method for the quantitation of DCS was developed and calibrated to be used for this study. The partition coefficient was determined and compared with the predicted value. The solution stability of DCS was studied under various pH (2.0-11.5) and ionic strengths of 10 and 20 mM at physiological temperature of 37°C. The 250 mg capsule was compounded to the nominal strength of 50 mg used for anxiety disorders. These capsules were then put under stability. The in vitro dissolution was also carried out at 37°C as per the United States Pharmacopeia (USP) guidelines. The partition coefficient value (Kp) determined for the DCS was log Kp = -2.89 ± 0.06 (n = 6). The pH-solution stability profile shows that DCS has maximum stability under alkaline conditions. The maximum rate of degradation was seen at pH of 4.7. The mean percent recovery of DCS from the capsules compounded to strength of 50 mg was 100.3 ± 1.4. The stability study of the reformulated capsules concluded that reformulated DCS is stable for at least one year at room temperature. The in vitro dissolution illustrates that all the DCS is released from the capsules in 10 min. The present characterization of DCS study will serve as guidance for the future directions regarding the reformulation of DCS in order to be used in anxiety disorders.
Collapse
Affiliation(s)
- G Kaushal
- School of Pharmacy, University of Charleston, Charleston, WV, USA
| | | | | | | | | | | |
Collapse
|
44
|
Christen T, Koch N, Philandrianos C, Ramirez R, Raffoul W, Beldi M, Casanova D. The V-Y latissimus dorsi musculocutaneous flap in the reconstruction of large posterior chest wall defects. Aesthetic Plast Surg 2012; 36:618-22. [PMID: 22258838 DOI: 10.1007/s00266-011-9866-x] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/19/2011] [Accepted: 12/13/2011] [Indexed: 10/14/2022]
Abstract
UNLABELLED Posterior chest wall defects are frequently encountered after excision of tumors as a result of trauma or in the setting of wound dehiscence after spine surgery. Various pedicled fasciocutaneous and musculocutaneous flaps have been described for the coverage of these wounds. The advent of perforator flaps has allowed the preservation of muscle function but their bulk is limited. Musculocutaneous flaps remain widely employed. The trapezius and the latissimus dorsi (LD) flaps have been used extensively for upper and middle posterior chest wounds, respectively. Their bulk allows for obliteration of the dead space in deep wounds. The average width of the LD skin paddle is limited to 10-12 cm if closure of the donor site is expected without skin grafting. In 2001 a modification of the skin paddle design was introduced in order to allow large flaps to be raised without requiring grafts or flaps for donor site closure. This V-Y pattern allows coverage of large anterior chest defects after mastectomy. We have modified this flap to allow its use for posterior chest wall defects. We describe the flap design, its indications, and its limitations with three clinical cases. LEVEL OF EVIDENCE V This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors at www.springer.com/00266.
Collapse
|
45
|
Peyrani P, Allen M, Seligson D, Roberts C, Chen A, Haque N, Zervos M, Wiemken T, Harting J, Christensen D, Ramirez R. Clinical outcomes of osteomyelitis patients infected with methicillin-resistant Staphylococcus aureus USA-300 strains. Am J Orthop (Belle Mead NJ) 2012; 41:117-122. [PMID: 22530208] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/31/2023]
Abstract
Methicillin-resistant Staphylococcus aureus (MRSA) USA-300 strains have emerged as an important cause of community-acquired infections. These strains have been recognized as an etiology of osteomyelitis but data on their incidence and outcomes are limited. We retrospectively studied the incidence and clinical outcomes of MRSA USA-300 osteomyelitis in patients at the University of Louisville Hospital and the Henry Ford Health System between January 2007 and March 2008. Pulsed-field gel electrophoresis was used to determine USA type. Clinical outcomes were defined as management success versus failure at 12 months. Chi-square tests, Fisher exact tests, and Mann-Whitney tests were used to compare patient characteristics on the basis of clinical outcomes and USA type. Of the 50 patients with MRSA osteomyelitis, 27 (54%) had the USA-300 strain. Clinical failure was identified in 22% (6/27) of the patients with MRSA USA-300 and in 30% (7/23) of the patients with MRSA non-USA-300 osteomyelitis (P = .509). Our results showed that MRSA USA-300 is a significant etiology of MRSA osteomyelitis. With current surgical and medical management, outcomes of patients with MRSA USA-300 osteomyelitis are similar to those of patients with MRSA non-USA-300 osteomyelitis.
Collapse
Affiliation(s)
- P Peyrani
- University of Louisville, Louisville, Kentucky 40202, USA
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
46
|
Martin-Malo A, Merino A, Carracedo J, Alvarez-Lara MA, Ojeda R, Soriano S, Crespo R, Ramirez R, Aljama P. Effects of intravenous iron on mononuclear cells during the haemodialysis session. Nephrol Dial Transplant 2011; 27:2465-71. [DOI: 10.1093/ndt/gfr711] [Citation(s) in RCA: 45] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
47
|
Abstract
Gallbladder agenesis is a rare entity with an estimated incidence of 10-65 per 100,000. Females are more commonly affected (ratio 3:1), typically presenting in the 2nd or 3rd decade of life. Despite an absent gallbladder, half of patients present with symptoms similar to biliary colic, which is poorly understood. Clinicians should have a strong index of suspicion if nonvisualization is suggested by an ultrasound. HIDA scans are typically not helpful since nonvisualization of the gallbladder remains typical of cystic duct obstruction as well as of agenesis. While there are no specific guidelines for management of gallbladder agenesis, conservative management with smooth muscle relaxants is preferred. Sphincterotomy also has been reported in severe cases. Here, we report a case of a 21-year-old woman who presented with recurrent biliary colic and was diagnosed to have gallbladder agenesis on magnetic resonance cholangiopancreatography. A comparison with other cases and a review of the literature are presented.
Collapse
Affiliation(s)
- Pashtoon Murtaza Kasi
- International Scholars Program, University of Pittsburgh Medical Center (UPMC), Pittsburgh, Pa., USA
| | | | | | | | | |
Collapse
|
48
|
Kang YS, Cha JJ, Hyun YY, Lee MH, Song HK, Cha DR, Bang K, Jeong J, Shin JH, Kang JH, Yang J, Ahn C, Kim JH, Toledo K, Merino A, GonzaLez-Burdiel L, Perez-Saez MJ, Aguera M, Ramirez R, Del Castillo D, Aljama P, Kahveci A, Tugtepe H, Asicioglu E, Nalcaci S, Birdal G, Arikan H, Koc M, Tuglular S, Kaya H, Ozener C, Kocak G, Azak A, Huddam B, Astarci HM, Can M, Duranay M, Tayama Y, Hasegawa H, Takayanagi K, Matsuda A, Shimizu T, Asakura J, Iwashita T, Okazaki S, Hatano M, Kiba T, Ogawa T, Mitarai T, Sanchez JE, Nunez M, Gonzalez I, Fernandez-Vina A, Pelaez B, Quintana A, Rodriguez C, Park KA, Kim EJ, Choi SJ, Kim NR, Park MY, Kim JK, Hwang SD, Cotovio P, Rocha A, Carvalho MJ, Teixeira L, Mendonca D, Rodrigues A, Cabrita A, Ito M, Wu HY, Peng YS, Huang JW, Hu FC, Hung KY, Tsai TJ, Wu KD, Temiz G, Sahin G, Degirmenci N, Ozkurt S, Yalcin AU, Rufino M, Garcia C, Vega N, Macia M, Rodriguez A, Maceira B, Hernandez D, Lorenzo V, Levallois J, Nadeau-Fredette AC, Labbe AC, Laverdiere M, Ouimet D, Vallee M, Matsuda A, Katou H, Tayama Y, Iwanaga M, Ogawa T, Shimizu T, Asakura J, Noiri C, Kanouzawa K, Hasegawa H, Mitarai T, Karakan S, Sezer S, Ozdemir Acar N, Haberal M, Ueda A, Nagai K, Morimoto M, Hirayama A, Yoh K, Saito C, Yamagata K, Parikova A, Vlijm A, deGraaff M, Brabcova I, Viklicky O, Krediet R, Nagamine N, Katoh KI, Yoshitake O, Cho KH, Jung SY, Do JY, Park JW, Yoon KW, Hwang SD, Kim NR, Kim EJ, Chung CH, Park MY, Choi SJ, Kim JK, Mravljak M, Karas B, Pajek J, Pintar T, Benedik M, Gucek A, Tomo T, Kadota JI, Tsuchida K, Minakuchi J, Yamanaka M, Numata A, Masakane I, Fujimori A, Kawanishi H, Naito H, Bordignon J, Manonelles A, Andujar A, Gonzalez-Segura C, Gonzalez MT, Glavas-Boras S, Zlopasa G, Boras S, Smalcelj R, Slavicek J, Knezevic N, Puretic Z, Prasad N, Gupta A, Sinha A, Saxena A, Sharma RK, Kaul A, Ramos R, Gonzalez MT, Vera M, Garcia I, Barbosa F, Teixido J, Garcia C, Cuxart M, Gonzalez C, de la Cruz JJ, Fukuoka K, Sinozaki M, Kato N, Oba I, Harada K, Kanai H, Ota K, Do JY, Kang SW, Cho KH, Park JW, Shin KL, Kim YH, Yoon KW, Prasad N, Gupta A, Sinha A, Sharma RK, Kaul A, Saxena A, Schneider K, Huszar T, Bator B, Di Napoli A, Franco F, Salvatori MF, Di Lallo D, Guasticchi G, Hassan S, Kristal B, Khazim K, Hassan F, Hassan K, Korabecna M, Krizkova V, Kocova J, Tonar Z, Opatrna S, Gaiao S, Beco A, Oliveira A, Santos-Araujo C, Pestana M, Denizot A, Milliard B, Kahveci A, Asicioglu E, Arikan H, Tuglular S, Ozener C, Hsu BG, Lai YH, Wang CH, Fang TC, Yesil H, Paydas S, Balal M, Cinkir U, Sertdemir Y, Santos-Araujo C, Oliveira A, Beco A, Sousa J, Silva N, Santos D, Pestana M, Oliveira A, Beco A, Santos C, Pestana M, Vera M, Fontsere N, Maduell F, Arias M, Bergada E, Cases A, Campistol JM, Grzelak T, Czyzewska K, Mortazavi M, Seirafian S, Halabian M, Emami Naini A, Farajzadegan Z, Moinzade F, Golabchi K, Portoles J, Moreno F, Lopez-Sanchez P, Gomez M, Corchete E, del Peso G, Bajo MA, Rivera M, Arribas G, Ferreira AC, Fernandes V, Sousa J, Vila Lobos A, Nolasco F, Martino F, di Loreto P, Rodighiero MP, Crepaldi C, Ronco C, Asicioglu E, Kahveci A, Nalcaci S, Arikan H, Tuglular S, Ozener C, Cavallini M, Centi A, Broccoli ML, Rocca AR, Testorio M, Borzacca B, Pugliese F, Russo GE, Tokgoz B, Ucar C, Kocyigit I, Somdas MA, Unal A, Vural A, Sipahioglu MH, Oymak O, Utas C, Teixeira L, Rodrigues A, Carvalho MJ, Cabrita A, Mendonca D, Micha T, Takouli L, Karaitianou A, Koupari G, Trompouki S, Arvanitis D, Vlassopoulos D, Ferreira AC, Fernandes V, Vila Lobos A, Nolasco F, Kahveci A, Nalcaci S, Asicioglu E, Birdal G, Arikan H, Tuglular S, Ozener C, Carvalho C, Beco A, Oliveira A, Santos C, Pestana M, Hiramatsu M, Ishida M, Tonozuka Y, Mikami H, Yamanari T, Momoki N, Onishi A, Maruyama K, Ito M, Masakane I, Takahashi T, Chung SH, Han DC, Noh H, Jeon JS, Kwon SH, Lindholm B, Lee HB, Tekeli L, Inal S, Derici U, Celik N, Kiran G, Derin O, Durunay M, Erten Y, Cho JH, Do JY, Park SH, Kim CD, Choi JY, Ryu HM, Kim YL, Kawahara K, Ishihara Y, Iwadou H, Uemura N, Kinashi M, Oobayashi S, Pilcevic D, Tadic-Pilcevic J, Kovacevic Z, Maksic D, Paunic Z, Mitrovic M, Mijuskovic M, Petrovic M. Peritoneal dialysis. Clin Kidney J 2011. [DOI: 10.1093/ndtplus/4.s2.54] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
49
|
Lo CW, Liu X, Subramanian R, Tobita K, Tsuchya M, Kim A, Leatherubry L, Devine W, Kim Y, Anderton S, Wong L, Chang C, Ramirez R. High Throughput Congenital Heart Disease Phenotyping in Mice with Noninvasive Fetal Echocardiography. FASEB J 2011. [DOI: 10.1096/fasebj.25.1_supplement.181.2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
| | - X Liu
- Dept of Developmental BiologyUniversity of PittsburghPittsburghPA
| | - R Subramanian
- Dept of Developmental BiologyUniversity of PittsburghPittsburghPA
| | - K Tobita
- Dept of Developmental BiologyUniversity of PittsburghPittsburghPA
| | - M Tsuchya
- Dept of Developmental BiologyUniversity of PittsburghPittsburghPA
| | - A Kim
- Dept of Developmental BiologyUniversity of PittsburghPittsburghPA
| | | | - W Devine
- Children's Hospital of PittsburghPittsburghPA
| | - Y Kim
- Dept of Developmental BiologyUniversity of PittsburghPittsburghPA
| | - S Anderton
- Dept of Developmental BiologyUniversity of PittsburghPittsburghPA
| | - L Wong
- Dept of Developmental BiologyUniversity of PittsburghPittsburghPA
| | - C Chang
- Dept of Developmental BiologyUniversity of PittsburghPittsburghPA
| | - R Ramirez
- Dept of Developmental BiologyUniversity of PittsburghPittsburghPA
| |
Collapse
|
50
|
Weber M, Martin SS, Ramirez R, Fitzgerald J, Markert U. Kinetics of PIAS1/3 expression in early murine placenta. J Reprod Immunol 2010. [DOI: 10.1016/j.jri.2010.08.058] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|